Premerger Notification; Reporting and Waiting Period Requirements, 77042-77053 [2020-21754]
Download as PDF
77042
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
information believed to be confidential,
and one copy of the document marked
‘‘non-confidential’’ with the information
believed to be confidential deleted.
Submit these documents via email or on
a CD, if feasible. DOE will make its own
determination about the confidential
status of the information and treat it
according to its determination.
It is DOE’s policy that all comments
may be included in the public docket,
without change and as received,
including any personal information
provided in the comments (except
information deemed to be exempt from
public disclosure).
VI. Approval of the Office of the
Secretary
The Secretary of Energy has approved
publication of this notification of
proposed determination.
List of Subjects in 10 CFR Part 430
Administrative practice and
procedure, Confidential business
information, Energy conservation,
Household appliances, Imports,
Intergovernmental relations, Reporting
and recordkeeping requirements, and
Small businesses.
Signing Authority
khammond on DSKJM1Z7X2PROD with PROPOSALS10
This document of the Department of
Energy was signed on November 24,
2020, by Daniel R Simmons, Assistant
Secretary for Energy Efficiency and
Renewable Energy, pursuant to
delegated authority from the Secretary
of Energy. That document with the
original signature and date is
maintained by DOE. For administrative
purposes only, and in compliance with
requirements of the Office of the Federal
Register, the undersigned DOE Federal
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
the Department of Energy. This
administrative process in no way alters
the legal effect of this document upon
publication in the Federal Register.
Signed in Washington, DC, on November
24, 2020.
Treena V. Garrett,
Federal Register Liaison Officer, U.S.
Department of Energy.
[FR Doc. 2020–26327 Filed 11–30–20; 8:45 am]
BILLING CODE 6450–01–P
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
FEDERAL TRADE COMMISSION
16 CFR Parts 801, 802 and 803
RIN 3084–AB46
Premerger Notification; Reporting and
Waiting Period Requirements
Federal Trade Commission.
Advance notice of proposed
rulemaking.
AGENCY:
ACTION:
The Federal Trade
Commission (‘‘FTC’’ or ‘‘Commission’’)
is issuing this advance notice of
proposed rulemaking (‘‘ANPRM’’) to
gather information, related to seven
topics, that will help to determine the
path for future amendments to the
premerger notification rules (‘‘the
Rules’’) under the Hart-Scott-Rodino
Antitrust Improvements Act (‘‘the Act’’
or ‘‘HSR’’).
DATES: Comments must be received on
or before February 1, 2021.
ADDRESSES: Interested parties may file a
comment online or on paper, by
following the instructions in the
Invitation to Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write ‘‘16 CFR parts 801–803:
Hart-Scott-Rodino Rules ANPRM,
Project No. P110014’’ on your comment.
File your comment online at https://
www.regulations.gov by following the
instructions on the web-based form. If
you prefer to file your comment on
paper, mail your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW, Suite
CC–5610, (Annex J), Washington, DC
20580, or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW,
5th Floor, Suite 5610 (Annex J),
Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT:
Robert Jones (202–326–3100), Assistant
Director, Premerger Notification Office,
Bureau of Competition, Federal Trade
Commission, 400 7th Street SW, Room
CC–5301, Washington, DC 20024.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Invitation to Comment
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before February 1, 2021. Write ‘‘16 CFR
parts 801–803: Hart-Scott-Rodino Rules
ANPRM, Project No. P110014’’ on your
comment. Your comment—including
your name and your state—will be
placed on the public record of this
proceeding, including, to the extent
practicable, on the https://
www.regulations.gov website.
PO 00000
Frm 00029
Fmt 4702
Sfmt 4702
Because of the public health
emergency in response to the COVID–19
outbreak and the agency’s heightened
security screening, postal mail
addressed to the Commission will be
subject to delay. We strongly encourage
you to submit your comment online
through the https://www.regulations.gov
website. To ensure the Commission
considers your online comment, please
follow the instructions on the webbased form.
If you file your comment on paper,
write ‘‘16 CFR parts 801–803: HartScott-Rodino Rules ANPRM, Project No.
P110014’’ on your comment and on the
envelope, and mail your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW, Suite
CC–5610, (Annex J), Washington, DC
20580, or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW,
5th Floor, Suite 5610 (Annex J),
Washington, DC 20024. If possible,
please submit your paper comment to
the Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible website,
https://www.regulations.gov, you are
solely responsible for making sure your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include sensitive personal information,
such as your or anyone else’s Social
Security number; date of birth; driver’s
license number or other state
identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential,’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
E:\FR\FM\01DEP1.SGM
01DEP1
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS10
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the FTC General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted publicly at
www.regulations.gov—as legally
required by FTC Rule 4.9(b)—we cannot
redact or remove your comment, unless
you submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
Visit the FTC website to read this
document and the news release
describing it. The FTC Act and other
laws that the Commission administers
permit the collection of public
comments to consider and use in this
proceeding as appropriate. The
Commission will consider all timely
and responsive public comments it
receives on or before February 1, 2021.
For information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
Overview
The Act and Rules require the parties
to certain mergers and acquisitions to
file notifications with the Commission
and the Assistant Attorney General in
charge of the Antitrust Division of the
Department of Justice (‘‘the Assistant
Attorney General’’) (collectively, ‘‘the
Agencies’’) and to wait a specified
period of time before consummating
such transactions. The reporting and
waiting period requirements are
intended to enable the Agencies to
determine whether proposed mergers or
acquisitions may violate the antitrust
laws if consummated and, when
appropriate, to seek injunctions in
federal court to prohibit anticompetitive
transactions prior to consummation.
Section 7A(d)(1) of the Clayton Act,
15 U.S.C. 18a(d)(1), directs the
Commission, with the concurrence of
the Assistant Attorney General, in
accordance with the Administrative
Procedure Act, 5 U.S.C. 553, to require
that premerger notification be in such
form and contain such information and
documentary material as may be
necessary and appropriate to determine
whether the proposed transaction may,
if consummated, violate the antitrust
laws. In addition, Section 7A(d)(2) of
the Clayton Act, 15 U.S.C. 18a(d)(2),
grants the Commission, with the
concurrence of the Assistant Attorney
General, in accordance with 5 U.S.C.
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
553, the authority to define the terms
used in the Act, exempt classes of
transactions that are not likely to violate
the antitrust laws, and prescribe such
other rules as may be necessary and
appropriate to carry out the purposes of
Section 7A.
Since the enactment of the Act, the
Commission has updated and refined
the Rules many times. Indeed, the
Agencies have a strong interest in
making sure the Rules are as current and
relevant as possible. Certain rules
interpreting and implementing the Act,
some of which have not been changed
since they were first promulgated in
1978, may need additional updating. In
this ANPRM, the Commission proposes
to gather information on seven topics to
help determine the path for potential
future amendments to numerous
provisions of Parts 801, 802, and 803 of
the Rules under the Act.
Background
Although it regularly reviews the
Rules and revises them on a rolling
basis, the Commission is issuing this
ANPRM to solicit information to
support review of the Rules on a more
unified basis as part of its systematic
review of all FTC rules and guides. The
Commission is aware that market and
business practices are constantly
evolving, and that these changes make
it especially important to evaluate
whether the Rules are still serving their
intended purpose or if they need to be
amended, eliminated, or supplemented.
To accomplish this, the Commission
is publishing in this ANPRM a number
of questions related to seven different
topics about which questions frequently
arise in discussions of the Rules: Size of
Transaction, Real Estate Investment
Trusts, Non-Corporate Entities,
Acquisitions of Small Amounts of
Voting Securities, Influence outside the
Scope of Voting Securities, Devices for
Avoidance, and Filing Issues. Answers
to questions on these topics will provide
information that may facilitate drafting
of new or revised rules.
The Commission welcomes comments
on all of these topics, or on any subtopic within them. The Commission,
however, does not expect that every
commenter will address all seven
topics, or even every question relating to
each topic. The Commission notes that
comments it receives in response to this
ANPRM may also inform the Notice of
Proposed Rulemaking regarding the
proposed change in the § 801.1(a)(1)
definition of ‘‘person’’ and proposed
exemption § 802.15 published in the
Federal Register at the same time as this
ANPRM.
PO 00000
Frm 00030
Fmt 4702
Sfmt 4702
77043
I. Size of Transaction
Section 7A(a)(2) of the Clayton Act
mandates an HSR filing when a
transaction meets the Size of
Transaction (‘‘SOT’’) test, subject to
other provisions of the Rules, including
exemptions.1 To determine whether a
transaction meets the SOT test, filing
parties must look to Acquisition Price
(‘‘Acquisition Price’’) under 16 CFR
801.10 or, in some cases, Fair Market
Value (‘‘FMV’’) under 16 CFR
801.10(c)(3). As it is the filing parties’
responsibility to conduct these
calculations, the Commission would
benefit from additional information on
how filing parties engage in the
calculation for both Acquisition Price
and FMV.
A. Acquisition Price (16 CFR 801.10)
Under 16 CFR 801.10(c)(2), the
Acquisition Price ‘‘shall include the
value of all consideration for such
voting securities, non-corporate
interests, or assets to be acquired.’’ 2 The
FTC’s Premerger Notification Office
(‘‘the PNO’’) has long taken the position
that, when a transaction has a
determined Acquisition Price, debt may
be excluded from the Acquisition Price
in certain circumstances. For example,
if a buyer pays off a target’s debt as part
of the transaction, the buyer may deduct
the amount of the retired debt from the
Acquisition Price. This position dates
from the earliest days of interpreting the
HSR Rules in the late 1970s and early
1980s and is based, in part, on the
analysis of a target’s balance sheet
liabilities in the context of an
acquisition of voting securities.
The PNO has also allowed the
deduction of certain expenses when
calculating the Acquisition Price. For
example, where the purchase price in
the parties’ transaction agreement
includes funds earmarked to pay off the
seller’s transaction expenses, the PNO
has permitted the parties to deduct that
amount when calculating the
Acquisition Price based on the view that
such payments do not reflect
consideration for the target.
The Commission is aware that these
informal PNO staff positions can have a
significant impact on the calculation of
the Acquisition Price and, in turn, on
whether a transaction is reportable
under the Act. Given the potential for
these positions to affect the structure of
a transaction, the Commission believes
1 Steps for Determining Whether an HSR Filing is
Required, FTC.GOV, https://www.ftc.gov/
enforcement/premerger-notification-program/hsrresources/steps-determining-whether-hsr-filing (last
visited July 07, 2020).
2 16 CFR 801.10(c)(2).
E:\FR\FM\01DEP1.SGM
01DEP1
khammond on DSKJM1Z7X2PROD with PROPOSALS10
77044
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
these informal PNO staff positions may
need revision. As a result, the
Commission aims to understand the
decision-making involved in the
deduction of retired debt or other
amounts or categories of expenses from
the Acquisition Price through responses
to the following questions:
1. When negotiating a transaction,
does a buyer ever offer to pay off or
retire debt as part of the deal? Under
what circumstances? How have these
circumstances evolved since the late
1970s/early 1980s?
a. Why might a buyer offer to pay off
or retire debt as part of the deal now as
opposed to in the late 1970s/early
1980s? Have the competitive
implications of the deal ever been a
factor in this decision?
b. Why might a buyer decline to pay
off or retire debt as part of the deal now
as opposed to in the late 1970s/early
1980s? Have the competitive
implications of the deal ever been a
factor in this decision?
c. Does a seller prefer a buyer that is
willing to pay off or retire debt as part
of the deal? Why or why not? Are seller
preferences different now than in the
late 1970s/early 1980s?
d. In a multiple bid situation, is a
buyer’s willingness to pay off or retire
debt as part of the deal ever a factor in
the seller’s selection of the winning bid?
Was it a factor in the late 1970s/early
1980s? And if it is evaluated differently
today versus the 1970s/early 1980s, why
is it evaluated differently?
e. Do sellers ever reject a buyer’s offer
to pay off or retire debt as part of the
deal? Under what circumstances? How
have these circumstances evolved since
the late 1970s/early 1980s? Have the
competitive implications of the deal
ever been a factor in this decision?
f. Are there any limitations (legal or
otherwise) on a buyer’s ability to pay off
or retire debt as part of the deal? If so,
what are they? How do these limitations
differ from limitations in place in the
late 1970s/early 1980s?
g. Are buyers more or less likely to
pay off or retire debt as part of the deal
now than they were in the late 1970s/
early 1980s? Why or why not?
2. When negotiating a transaction,
does a buyer ever offer to pay other
expenses of or within the seller (e.g.,
legal or banking fees, change of control
payments, etc.) as part of the deal?
Under what circumstances? How have
these circumstances evolved since the
late 1970s/early 1980s?
a. Why might a buyer offer to pay
such expenses as part of the deal now
as opposed to in the late 1970s/early
1980s? Have the competitive
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
implications of the deal ever been a
factor in this decision?
b. Why might a buyer decline to pay
such expenses as part of the deal now
as opposed to in the late 1970s/early
1980s? Have the competitive
implications of the deal ever been a
factor in this decision?
c. Does a seller prefer a buyer that is
willing to pay such expenses as part of
the deal? Why or why not? Are seller
preferences different now than in the
late 1970s/early 1980s?
d. In a multiple bid situation, is a
buyer’s willingness to pay such
expenses as part of the deal ever a factor
in the seller’s selection of the winning
bid? Was it a factor in the late 1970s/
early 1980s? If it is evaluated differently
today versus the 1970s/early 1980s, why
is it evaluated differently?
e. Do sellers ever reject a buyer’s offer
to pay such expenses as part of the deal?
Under what circumstances? How have
these circumstances evolved since the
late 1970s/early 1980s? Have the
competitive implications of the deal
ever been a factor in this decision?
f. Are there any limitations (legal or
otherwise) on a buyer’s ability to pay
such expenses as part of the deal? If so,
what are they? Do these limitations
differ from limitations in place in the
late 1970s/early 1980s? If they differ,
how do they differ?
g. Are buyers more or less likely to
pay such expenses as part of the deal
now than they were in the late 1970s/
early 1980s? Why or why not?
3. How do parties currently calculate
the Acquisition Price? How has the
calculation changed since the late
1970s/early 1980s?
a. Under what conditions is the
Acquisition Price different from the
purchase price or consideration
identified in the transaction agreement?
Have these conditions changed since the
late 1970s/early 1980s? If they have
changed, how have they changed?
b. Do transaction agreements ever lack
a firm or certain purchase price? Under
what conditions? Have these conditions
changed since the late 1970s/early
1980s? If they have changed, how have
they changed?
i. Why would parties negotiate a deal
without a firm or certain purchase
price? What factors have affected such
a decision or deal structure? Have these
factors evolved since the late 1970s/
early 1980s? If they have changed, how
have they changed? Have the
competitive implications of the deal
ever been a factor in this negotiating a
deal without a firm or certain purchase
price?
ii. What are the limits on the scope of
the undetermined payments or
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
deductions? Have these limits changed
since the late 1970s/early 1980s? If they
have changed, how have they changed?
c. Can an Acquisition Price be subject
to undeterminable deductions or
deductions of undeterminable value?
Under what conditions? Have these
conditions evolved since the late 1970s/
early 1980s? If they have changed, how
have they changed? What are some
examples of each kind of deduction and
how have they changed since the late
1970s/early 1980s?
d. Are there certain categories of
consideration that are commonly
deducted or added when calculating the
Acquisition Price? Have these categories
changed since the late 1970s/early
1980s? If they have changed, how have
they changed?
e. Is the ultimate recipient of a
payment ever a factor in whether such
payment is included when calculating
the Acquisition Price? Why or why not?
In what circumstances? Has this
determination changed since the late
1970s/early 1980s? If it has changed,
how has it changed?
f. Is employee compensation (e.g.,
bonus payments, retention payments,
payments for contingent employee
compensation) ever included when
calculating the Acquisition Price? Why
or why not? In what circumstances? Has
this determination changed since the
late 1970s/early 1980s? If it has
changed, how has it changed?
g. Does the form of employee
compensation affect whether it is
included in the Acquisition Price?
Under what circumstances? Has this
determination changed since the late
1970s/early 1980s? If it has changed,
how has it changed?
h. Is the value of employee
compensation ever deducted from the
Acquisition Price? Why or why not?
Under what circumstances? Has this
determination changed since the late
1970s/early 1980s? If it has changed,
how has it changed?
i. Is there a ‘‘control premium’’
associated with the acquisition of
control? How does an Acquiring Person
determine that ‘‘control premium’’? Has
this determination changed since the
late 1970s/early 1980s? If it has
changed, how has it changed?
4. When calculating the Acquisition
Price, do parties include all
consideration paid for the target? How
has this approach changed since the late
1970s/early 1980s?
a. How do parties define
‘‘consideration?’’ Has this changed since
the late 1970s/early 1980s? If it has
changed, how has it changed?
b. Do parties rely on a standard legal
definition for ‘‘consideration?’’ If so,
E:\FR\FM\01DEP1.SGM
01DEP1
khammond on DSKJM1Z7X2PROD with PROPOSALS10
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
what is it and from what is it derived?
Has this changed since the late 1970s/
early 1980s? If it has changed, how has
it changed?
c. Is consideration defined any
differently for the purposes of
calculating Acquisition Price than it is
for non-HSR purposes? Why or why
not? Has this changed since the late
1970s/early 1980s? If it has changed,
how has it changed?
d. Are any categories of payments
excluded from the above definition of
‘‘consideration?’’ Why or why not? Has
this changed since the late 1970s/early
1980s? If it has changed, how has it
changed?
e. Is the ultimate recipient of the
payment ever a factor in whether such
payment is included as consideration?
Why or why not? Has this changed since
the late 1970s/early 1980s? If it has
changed, how has it changed?
5. When calculating the Acquisition
Price, how does debt affect the
calculation? How has this approach
changed since the late 1970s/early
1980s?
a. Does the debt reported on the
target’s balance sheet affect the
calculation of the Acquisition Price?
Why or why not? In what
circumstances? Should it? Why or why
not? Has this changed since the late
1970s/early 1980s? If it has changed,
how has it changed?
b. Does the buyer’s pay off or
retirement of debt affect the calculation
of the Acquisition Price? Why or why
not? In what circumstances? Should it?
Why or why not? Has this changed since
the late 1970s/early 1980s? If it has
changed, how has it changed?
c. Does the treatment of debt (either
reported on a balance sheet or being
paid off or retired by the buyer) differ
based on whether the acquisition is of
(1) voting securities, (2) non-corporate
interests, or (3) assets? Why or why not?
Should it? Why or why not? Has this
changed since the late 1970s/early
1980s? If it has changed, how has it
changed?
d. Should the calculation of
Acquisition Price focus on the total
amount paid by the Acquiring Person
(including debt that is paid off or
retired) or the net amount received by
the Acquired Person (excluding debt
that is paid off or retired)? Why? Has
this changed since the late 1970s and
early 1980s? If it has changed, how has
it changed?
6. Where an acquisition is of voting
and non-voting securities, how is the
Acquisition Price allocated between the
voting securities and the non-voting
securities? How has this approach
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
changed since the late 1970s/early
1980s?
a. Are the voting securities and nonvoting securities separately valued?
Why or why not? Has this changed since
the late 1970s/early 1980s? If it has
changed, how has it changed?
b. Are each of the voting securities
and the non-voting securities valued?
Why or why not? Has this changed since
the late 1970s and early 1980s? If it has
changed, how has it changed?
B. Fair Market Value (16 CFR
801.10(c)(3))
Sometimes a transaction does not
have a determined Acquisition Price.
This is often due to the fluctuation in
stock prices or the inability to calculate
the exact amount of contingent future
payments. As a result, the Fair Market
Value (‘‘FMV’’) of the transaction
becomes critical to determining
reportability under the Act.
Per § 801.10(c)(3), FMV ‘‘shall be
determined in good faith by the board
of directors of the ultimate parent entity
included within the Acquiring Person,
or, if unincorporated, by officials
exercising similar functions; or by an
entity delegated that function by such
board or officials.’’ Once the Acquiring
Person, or its delegate, has determined
the FMV, there is no requirement to
share with the Agencies the details of
how that FMV was determined. The
Commission would like to understand
better the determination of FMV
through responses to the following
questions:
1. When an Acquiring Person is
evaluating the potential acquisition of
voting securities, non-corporate
interests, or assets, what methodologies
does that Acquiring Person use to
support valuation in the ordinary course
of due diligence and negotiation of the
acquisition? How have these
methodologies changed since the late
1970s/early 1980s?
a. If an acquisition involves the
acquisition of non-voting securities,
what methodologies does the Acquiring
Person use to value the non-voting
securities? Have these methodologies
changed since the late 1970s/early
1980s? If they have changed, how have
they changed?
b. In an acquisition of both voting
securities and non-voting securities,
does the Acquiring Person ever use one
methodology to value the voting
securities and a different methodology
to value the non-voting securities? Why
or why not? Have these methodologies
changed since the late 1970s/early
1980s? If they have changed, how have
they changed?
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
77045
c. Where the Acquiring Person
receives board appointment or board
designation rights (or their noncorporate equivalent) in conjunction
with the acquisition of voting (or nonvoting) securities, do those rights affect
the FMV of the voting (or non-voting)
securities acquired? Has this changed
since the late 1970s/early 1980s? If this
has changed, how has it changed?
2. How does the determination of
FMV under 16 CFR 801.10(c)(3) differ
from the Acquiring Person’s
determination of value in the ordinary
course of due diligence and negotiation
of an acquisition? How has this
determination changed since the late
1970s/early 1980s?
a. What factors go into determining
FMV? Do these factors vary by industry,
type of acquisition (asset, non-corporate
interest, intellectual property), size of
the target, or for other reasons? Describe
each of the ways these factors vary and
how each one varies. How have these
factors changed since the late 1970s/
early 1980s? Are there difficulties
involved in performing FMV analyses?
If so, what are those difficulties? Have
these difficulties changed since the late
1970s/early 1980s? If they have
changed, how have they changed? What
additional guidance, if any, might the
Commission provide to eliminate these
difficulties?
b. How often and for what purposes
do boards of directors rely on thirdparty bankers and other appraisers to
provide FMV analysis? Do boards of
directors evaluate the accuracy of those
results compared to their own
calculations? If so, how does the board
of directors evaluate the accuracy of
those results? Has this process changed
since the late 1970s/early 1980s? If it
has changed, how has it changed?
c. Should the Commission require an
independent FMV analysis for some
transactions to ensure consistency with
standard valuation practices? If so, for
what type of transactions should the
Commission require independent FMV
analysis? If the Commission requires an
independent analysis, who should
conduct the FMV analysis?
3. When calculating the FMV because
the Acquisition Price is not determined
as a result of future or uncertain
payments, what financial or valuation
concepts are used to determine the
value of those future or uncertain
payments? Have these concepts changed
since the late 1970s/early 1980s? If they
have changed, how have they changed?
4. How does an Acquiring Person
determine the present FMV of assets
that are not yet commercialized? For
example, how does an Acquiring Person
determine the present FMV of
E:\FR\FM\01DEP1.SGM
01DEP1
77046
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS10
intellectual property surrounding a
product that currently is under
development? Has this determination
changed since the late 1970s/early
1980s? If it has changed, how has it
changed?
5. In determining the FMV, how does
the Acquiring Person account for the
value of any assumed liabilities (or
liabilities of the Acquired Entity)? What
impact do such liabilities have on the
FMV? Has this determination changed
since the late 1970s/early 1980s? If it
has changed, how has it changed?
6. Should the Commission require the
Acquiring Person to provide the basis
for its FMV determination? If so, why?
If not, why not?
II. Real Estate Investment Trusts
(Section 7A(c)(1) of the Clayton Act)
Congress created real estate
investment trusts (‘‘REITs’’) in 1960 to
allow for the pooling of funds from
many small investors to invest in real
estate, and gave REITs preferential tax
treatment. The legislative history
indicates that REIT status was meant to
be limited to ‘‘clearly passive income
from real estate investments, as
contrasted to income from the active
operation of businesses involving real
estate,’’ and those real estate trusts
engaging in active business operations
would not be afforded REIT tax status.3
As a result, the PNO has long taken
the informal staff position that when a
REIT acquires real property (and assets
incidental to the real property), the
acquisition is exempt from HSR
reporting under section 7A(c)(1) of the
Clayton Act, the statutory ordinary
course of business exemption. This
position is based on the presumption
that REITs are solely buying, owning,
leasing, and selling real property, and
therefore any acquisition of real
property is exempt because it is done in
the ordinary course of the REIT’s
business and is unlikely to violate the
antitrust laws.
The Commission is aware that the
Internal Revenue Service (‘‘IRS’’)
subsequently made changes in tax law
to remove restrictions on REITs and
expand the beneficial tax treatment. As
a result, many REITs are no longer
solely buying, owning, leasing, and
selling real property.4 In fact, many
REITs are now engaged in the active
operation of businesses. For instance,
REITs operate assisted living and other
healthcare businesses, as well as
companies that own cell towers and
3 H.R.
Rep. No. 86–2020, pt. 2, at 3–4 (1960).
4 Proposed Rulemaking, 79 FR 27508 (May 14,
2014); Correction to Proposed Rulemaking, 79 FR
38809 (July 9, 2014); Final Regulations, 81 FR
59849 (Aug. 31, 2016).
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
billboards, located on REIT-owned real
property. Due to these changes, the
Commission believes it is possible that
a REIT’s acquisition of real property
may no longer be suitable for the
blanket exemption offered under section
7A(c)(1) of the Act. The Commission
would like to understand in more detail
the current structure and operation of
REITs through responses to the
following questions:
1. Have REITs evolved from entities
that own only real property to entities
that can hold operating companies?
a. If so, what has led to the evolution
of REITs becoming entities that can hold
operating companies?
b. How have changes in tax laws or
regulations influenced this evolution?
2. How does an operating company
convert to a REIT?
a. Do REIT structures involve one
Ultimate Parent Entity (‘‘UPE’’)? Two
UPEs? How often is each type used?
Why?
b. If a REIT has more than one UPE,
what is the relationship between those
UPEs?
c. If a REIT has more than one UPE,
is there an entity above the UPEs that
makes decisions for both of them?
3. Is there a way to distinguish REITs
that own only real property from those
that hold operating companies? If yes,
what are the ways to distinguish REITs
that own only real property and those
that hold operating companies? For
instance, are there differences in how
they are structured? How else are they
different?
4. Assume the PNO’s informal staff
position exempting REITs did not exist
and REITs had to rely solely on the real
property exemptions, §§ 802.2 and
802.5.
a. Are there situations in which REIT
transactions would no longer be
exempt? If so, what kinds of situations?
b. How often would the §§ 802.2 and
802.5 exemptions come into play?
c. Would it be easy for REITs to apply
§§ 802.2 and 802.5 to transactions? If so,
why? If not, why not?
III. Non Corporate Entities (16 CFR
801.1f(1)(ii))
The Act applies to acquisitions of
voting securities or assets. The rise of
non-corporate entities, such as
partnerships and limited liability
companies, has presented challenges
under the Act because the PNO had long
taken the position that interests in
unincorporated entities were neither
voting securities nor assets. Thus, any
acquisition of interests in such entities
had not been a reportable event unless
100% of the interests was acquired, in
which case the acquisition was deemed
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
to be that of all of the underlying assets
of the partnership or other
unincorporated entity.’’ 5
At first, this approach did not present
significant issues, because noncorporate entities were created as
acquisition vehicles and used to
effectuate transactions, not to separately
hold operating businesses.6 But the role
of non-corporate entities evolved. As the
Commission noted in its 2004 Notice of
Proposed Rulemaking, ‘‘[t]he use of
unincorporated entities is expanding,
and such entities are increasingly
engaging in acquiring interests in other
corporate and unincorporated entities.
For example, the number of corporate
income tax filings increased from
4,630,000 to 5,711,000 (23%) between
1994 and 2002, while the number of
partnership returns, including LLCs
taxed as partnerships, increased from
1,550,000 to 2,236,000 (44%) during the
same period. In addition, a number of
states have amended their statutes in
recent years to allow limited liability
companies to merge with other types of
legal entities.’’ 7 As a result, the
Commission determined in its 2005
Final Rule that the acquisition of
control, 50% or more of the noncorporate interests (‘‘NCIs’’) in a noncorporate entity (‘‘NCE’’), would
henceforth be reportable.8
The Commission is aware that NCEs
have continued to evolve. For instance,
acquisitions of NCIs are often captured
in Securities Purchase Agreements,
which imply that NCIs are now deemed
to be more like voting securities. Thus,
the Commission believes that it is
appropriate to re-evaluate the nature of
NCEs and NCIs to determine whether
NCEs are the equivalent of corporate
entities and NCIs function more as
voting securities. To that end, the
Commission would like to understand
in more detail the evolution of NCEs
and NCIs since its 2005 Final Rule,9
through responses to the following
questions:
1. Have NCEs evolved in form and
substance since 2005? If they have
evolved, what significant changes have
occurred to shape the evolution of NCEs
between 2005 and now?
a. Have the distinctions between
NCEs and corporate entities evolved
since 2005? If they have evolved, what
significant changes have occurred to
make NCEs and corporate entities more
or less distinct between 2005 and now?
5 69
FR 18686, 18687 (Apr. 8, 2004).
Interpretation 15, 63 FR 54713 (Oct. 13,
1998) (amended 1999) (amended 2001).
7 69 FR at 18688.
8 70 FR 11502, 11504 (Mar. 8, 2005).
9 70 FR 11502 (Mar. 8, 2005).
6 Formal
E:\FR\FM\01DEP1.SGM
01DEP1
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
b. Have the distinctions between NCIs
and voting securities evolved since
2005? If they have evolved, what
significant changes have occurred to
make NCIs and voting securities more or
less distinct between 2005 and now?
c. Are NCIs currently the same as
voting securities? If so, how? If not, how
are they different? Is this different from
2005? If so, how? What has changed
between 2005 and now?
d. Does any category of NCIs currently
carry a right equivalent to the right to
vote for the election of the board of
directors of a corporate entity? Is this
different from 2005? If so, how? What
has changed between 2005 and now?
e. Should the reporting obligations for
the acquisition of an interest in a
corporate entity and non-corporate
entity differ? Is this different from 2005?
If so, how? What has changed between
2005 and now?
2. Have the benefits and drawbacks of
becoming an NCE evolved since 2005?
If they have evolved, have the
incentives to become an NCE changed
since 2005? If so, how? If not, why not?
What has changed between 2005 and
now?
khammond on DSKJM1Z7X2PROD with PROPOSALS10
IV. Acquisitions of Small Amounts of
Voting Securities (16 CFR 801.1, 802.9,
802.64)
Since the implementation of the HSR
program, there has been a significant
expansion of the holdings of investment
entities, including investment funds and
institutional investors, as well as
expanded interest and ability of such
shareholders to participate in corporate
governance.10 In addition, changes in
investment behavior have resulted in
some investment entities holding small
stakes in a large number of firms,
including competitors. This has caused
some to raise concerns about the
competitive effects of common
ownership—that is, the competitive
effect of an investor holding small
minority positions in issuers that
operate competing lines of business.11
10 See, e.g., Edward Rock, Adapting to the New
Shareholder-Centric Reality, 161 U. Pa. L. Rev. 1907
(2013).
11 Matthew Backus, Christopher Conlon, &
Michael Sinkinson, Common Ownership in
America: 1980–2017, forthcoming, American
Economic Journal (forthcoming 2020) https://
chrisconlon.github.io/site/common_owner.pdf.
(These concerns (and their validity) were discussed
at the Federal Trade Commission’s Hearings on
Competition and Consumer Protection in the 21st
Century, Hearings on Common Ownership (Dec. 6,
2018). The transcript of that session is available on
the FTC’s website, here: https://www.ftc.gov/
system/files/documents/public_events/1422929/ftc_
hearings_session_8_transcript_12-6-18_0.pdf, and
the slide presentations of the participants are
available here, https://www.ftc.gov/system/files/
documents/public_events/1422929/cpc-hearingsnyu_12-6-18.pdf.).
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
In light of these developments, the
Commission is using this ANPRM to
take a fresh look at the rules that apply
to acquisitions of voting securities by
investment entities to determine
whether updates may be necessary. The
Commission seeks information on the
following rules:
A. Definition of ‘‘Solely for the Purpose
of Investment’’ (16 CFR 801.1, 802.9)
Section (c)(9) of the HSR Act exempts
from the requirements of the Act
‘‘acquisitions, solely for the purpose of
investment, of voting securities, if, as a
result of such acquisition, the securities
acquired or held do not exceed 10 per
centum of the outstanding voting
securities of the issuer.’’ To implement
this statutory limitation, 16 CFR 802.9
exempts from the requirements of the
Act an acquisition of voting securities if
made solely for the purpose of
investment and if, as a result of the
acquisition, the Acquiring Person would
hold 10% or less of the outstanding
voting securities of the issuer, regardless
of the dollar value of the voting
securities so acquired or held. Under 16
CFR 801.1(i)(1), ‘‘[v]oting securities are
held or acquired ‘solely for the purpose
of investment’ if the person holding or
acquiring such voting securities has no
intention of participating in the
formulation, determination, or direction
of the basic business decisions of the
issuer.’’ 12
In light of changing investor
engagement with issuers, the
Commission is interested in knowing if
it is appropriate to rethink the definition
of ‘‘solely for the purpose of
investment’’ in 16 CFR 801.1(i)(1) and
the exemption in 16 CFR 802.9. To that
end, the Commission seeks to
understand the incentives involved in
applying the exemption in 16 CFR 802.9
through responses to the following
questions:
1. The ability to rely on 16 CFR 802.9
depends on whether a potential filing
person ‘‘has no intention of
participating in the formulation,
determination, or direction of basic
business decisions of the issuer.’’ 13
a. Are there benefits to this approach?
If so, what are the benefits?
b. Are there drawbacks to this
approach? If so, what are the
drawbacks?
c. How could this approach be
changed? How would such a change
impact investors and issuers?
d. What are the ‘‘basic business
decisions’’ of the issuer?
12 16
13 16
PO 00000
CFR 801.1(i)(1).
CFR 801.1(i)(1).
Frm 00034
Fmt 4702
Sfmt 4702
77047
i. Is it clear what decisions comprise
the ‘‘basic business decisions’’ of the
issuer?
ii. Are there activities that clearly do
not relate to the basic business
decisions?
iii. Are there activities that clearly do
relate to the basic business decisions?
iv. Is there uncertainty about whether
an activity relates to the basic business
decisions? If so, why is there
uncertainty? To what extent is there
uncertainty about whether an activity
relates to the basic business decisions?
e. Should the Commission define the
‘‘basic business decisions of the issuer’’
as used in the existing Rule?
i. What should the definition include?
ii. Should specific items be excluded
from the definition? Which items?
iii. What are the benefits of providing
a definition?
iv. What are the risks of providing a
definition?
f. Is it clear what is meant by ‘‘no
intention of participating’’ in the
formulation, determination, or direction
of the basic business decisions?
i. What type of activity related to
determining whether to participate in
business decisions currently takes one
out of the exemption, or at what point
in the process of deciding whether to
participate in business decisions is one
no longer within the exemption?
ii. What type of activity related to
determining whether to participate in
business decisions should result in the
exemption no longer applying, or at
what point in the process of deciding
whether to participate in business
decisions should one no longer be
within the exemption?
iii. Should the language be changed to
allow reliance on the exemption until
the Acquiring Person has made an
affirmative decision to participate in the
basic business decisions? If so, what
would constitute an affirmative decision
to participate in the basic business
decisions?
2. In general, for HSR purposes, what
differentiates the activities of investors
who invest solely for the purpose of
investment and investors who do not
invest solely for the purpose of
investment? Have these activities
changed since 1978? If so, how?
a. In what activities do investors who
invest solely for the purpose of
investment engage? Have these activities
changed since 1978? If so, how?
b. What categories of interaction with
management indicate an investor’s
intention is not to hold voting securities
solely for the purpose of investment?
For example, would those categories
include things like discussions of
governance issues, discussions of
E:\FR\FM\01DEP1.SGM
01DEP1
77048
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS10
executive compensation, or casting
proxy votes? Have these categories
changed since 1978? If so, how?
c. Does the market capitalization of
the issuer affect the determination of
whether an investment is solely for the
purpose of investment or not solely for
the purpose of investment? Has this
changed since 1978? If so, how?
3. How does the Commission’s
interpretation of ‘‘solely for the purpose
of investment’’ compare to the
Securities and Exchange Commission’s
(‘‘SEC’’) approach to ‘‘passive’’
investors? 14
a. Assuming no change in the SEC
approach, could the Commission adopt
the SEC approach? If yes, why? If no,
why not?
b. What would be the benefits of
adopting the SEC approach? Why?
c. What would be the drawbacks of
adopting the SEC approach? Why?
d. Does the different role of each
agency justify different approaches for
investors who hold positions solely for
the purpose of investment? If yes, why?
If no, why not?
4. How does the Commission’s
interpretation of ‘‘solely for the purpose
of investment’’ compare to the elements
that must be disclosed in Item 4 of
Schedule 13D filed with the SEC? 15
a. Assuming no change to the SEC
rule, could the Commission adopt the
SEC elements? If yes, why? If no, why
not?
b. What would be the benefits of
adopting the SEC elements?
14 Under SEC Rule 13d–1(c), certain beneficial
owners may file a short form statement on Schedule
13G in lieu of a 13D statement if that person ‘‘has
not acquired the securities with any purpose, or
with the effect, of changing or influencing the
control of the issuer, or in connection with or as
a participant in any transaction having that purpose
or effect, including any transaction subject to 17
CFR 240.13d–3(b), other than activities solely in
connection with a nomination under 17 CFR
240.14a–11.’’ 17 CFR 240.13d–1(c). The SEC relies
on a ‘‘control purpose’’ test to identify ‘‘passive’’
investments; that is, beneficial owners that acquired
shares ‘‘not with the purpose nor with the effect of
changing or influencing the control of the issuer.’’
The SEC has a broad view of the types of activities
that could show such a ‘‘control purpose,’’ and that
determination is assessed based on a totality of the
circumstances. For instance, a shareholder that fails
to qualify as an investor solely for the purpose of
investment under the HSR Act may nonetheless be
eligible to use Schedule 13G depending on various
factors, such as the subject matter of the
shareholder’s discussions with the issuer’s
management. See Exchange Act Sections 13(d) and
13(g) and Regulation 13D–G Beneficial Ownership
Reporting, Compliance and Disclosure
Interpretations (‘‘C&DIs’’), Question 103.11 (July 14,
2016) https://www.sec.gov/divisions/corpfin/
guidance/reg13d-interp.htm#103.11.
15 Item 4 of Schedule 13D requires filers to state
the purpose or purposes of the acquisition of
securities of the issuer and to describe any plans or
proposals which they might have. 17 CFR 240.13d–
10117 CFR 240.13d–101.
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
c. What would be the drawbacks of
adopting the SEC elements?
d. Does the different role of each
agency justify different approaches for
investors who hold positions solely for
the purpose of investment?
5. How do the activities of investment
firms differ from those of operating
companies?
a. Should the Commission treat
different types of acquirers differently
for the purpose of the exemption? If yes,
why? If no, why not?
b. Should the Commission treat
different types of investment companies
differently for the purpose of the
exemption (for example, mutual fund
companies versus hedge fund
companies)? If yes, why? If no, why not?
6. Should the Commission preclude
parties from using the exemption only if
they have taken certain specified
actions? If yes, why? If no, why not?
a. What actions should disqualify an
Acquiring Person from being able to use
the exemption?
i. Should the actions be limited to
actions that facilitate or encourage
coordination among competitors?
ii. Should actions that affect
competition, even if aimed only at a
single competitor, preclude the use of
the exemption? If yes, why? If no, why
not?
iii. Should actions that change the
incentives to compete, even if aimed
only at a single competitor, preclude the
use of the exemption? If yes, why? If no,
why not?
iv. What other actions should
preclude utilizing the exemption?
b. Would allowing the Acquiring
Person to acquire 9.9% of the voting
securities of the Issuer prior to taking
the specified action undercut the ability
to obtain filings early enough to
ascertain potential competitive harm
before a transaction is consummated? If
yes, why? If no, why not?
c. Would such a conditioning of the
loss of the exemption be consistent with
the wording of the statute, including
‘‘solely’’ and the ‘‘purpose’’ of the
acquisition? If yes, why? If no, why not?
i. Is the acquisition solely for
investment if the Acquiring Person is
considering taking action inconsistent
with the exemption, but has not yet
taken the action?
ii. Is the acquisition for the purpose
of investment if the Acquiring Person
has determined to take action
inconsistent with the exemption, but
has not yet taken the action?
d. Should the Commission require an
HSR filing for past acquisitions once the
specified actions have been taken? If
yes, why? If no, why not?
i. Would this be consistent with the
HSR Act’s requirement to make the
PO 00000
Frm 00035
Fmt 4702
Sfmt 4702
filing prior to the acquisition? If yes,
why? If no, why not?
ii. Would this be consistent with the
requirement that the Acquiring Person
certify that it has a good faith intent to
make an acquisition requiring
notification? If yes, why? If no, why not?
B. Definition of Institutional Investors
(16 CFR 802.64)
Under § 802.64, institutional investors
are exempt from HSR reporting when
making acquisitions of 15% or less of
voting securities in the ordinary course
of business and solely for purpose of
investment. During the initial HSR
rulemaking in 1978, entities were
identified as institutional investors
because they were viewed as
constrained by law (e.g., non-profits) or
fiduciary duty (e.g., pension trusts,
insurance companies, etc.), or generally
uninterested in ‘‘affecting management
of the companies whose stock they buy’’
(e.g., broker-dealers).16 The list
identifying what type of entity is
considered an institutional investor has
never been updated.
It is unclear to the Commission
whether this exemption should be
maintained and implemented in the
same manner in which it was first
promulgated in 1978. In light of changes
in the investor landscape since that
time, the Commission may need to
update the list of institutional investors
that are presumed to engage in
acquisitions solely for the purpose of
investment. Thus, the Commission aims
to understand the current institutional
investor landscape in order to make that
determination through responses to the
following questions:
1. Given that 16 CFR 802.64 has not
changed since 1978, does it need to be
updated?
a. Does 16 CFR 802.64 accurately
reflect the universe of entities that make
investments in the ordinary course of
business solely for the purpose of
investment? Are there entities currently
listed in the exemption that should be
removed? If so, why?
b. Are there entities not currently
listed that should be treated as
institutional investors? If so, why and
what are they? Explain the justification
for treating the entity as an institutional
investor: Does it fit within the paradigm
identified by the Commission in first
promulgating 16 CFR 802.64 (i.e., (i)
constrained by law; (ii) constrained by
fiduciary duty; or (iii) uninterested in
affecting management of the companies
whose stock they buy)? Are there other
reasons the entity should be treated as
an institutional investor?
16 43
E:\FR\FM\01DEP1.SGM
FR 33450, 33503 (July 31, 1978).
01DEP1
khammond on DSKJM1Z7X2PROD with PROPOSALS10
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
c. Should the Commission provide a
list of indicia that an investor must meet
to qualify as an institutional investor for
purposes of the HSR Act, instead of a
list of entities considered to be
institutional investors? If yes, why and
what should these indicia be? If no, why
not?
d. Is the 15% level for the
Commission’s exemption still consistent
with the purpose of the HSR Act? What
evidence is there that the level should
be higher or lower?
The SEC has also promulgated a
definition of ‘‘institutional investors’’ as
part of its beneficial ownership
disclosure requirements. When a person
or group of persons acquires beneficial
ownership of more than five percent of
a voting class of a company’s equity
securities registered under the
Securities Exchange Act, they are
required to file a Schedule 13D with the
SEC.17 Depending upon the facts and
circumstances, the person or group of
persons may be eligible to file the more
abbreviated Schedule 13G in lieu of
Schedule 13D.18 One of the exemptions
relates to acquisitions of securities in
the ordinary course of business by a
‘‘qualified institutional investor’’ under
Rule 13d–1(b).19
2. How does the Commission’s
definition of institutional investor
compare to the definition used by the
SEC in identifying a person able to file
a Schedule 13G?
a. Assuming no change in the SEC
rule, should the Commission adopt the
SEC definition of a person who acquires
voting securities in the ordinary course
of business and not with the purpose
nor with the effect of changing or
influencing the control of the issuer? If
yes, why? If no, why not?
b. What would be the benefits of
adopting the SEC definition?
c. What would be the drawbacks of
adopting the SEC definition?
d. Does the different role of each
agency justify different definitions for
institutional investors?
3. What are the activities of
institutional investors and how have
they changed since 1978?
a. What activities do institutional
investors engage in with the issuers
whose shares they hold? Have these
activities changed since 1978? If so, how
have these activities changed?
17 Securities Exchange Act of 1934, 15 U.S.C. 78a
et seq., and 17 CFR 240.13d–101.
18 Section 13(g) was added to the Exchange Act
as part of the Domestic and Foreign Investment
Improvement Disclosure Act of 1977. Public Law
95–214, sec. 203, 91. Stat. 1494.
19 Under SEC Rule 13d–1(b)(1)(i)–(ii)(A)–(K),
certain beneficial owners may file a short form
statement on Schedule 13G in lieu of a 13D
statement under certain conditions.
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
i. What is the scope of ‘‘shareholder
engagement’’ that institutional investors
undertake? Has this changed since
1978? If so, how has it changed?
ii. What topics or issues are the
subject of such engagement? Have these
topics or issues changed since 1978? If
so, how have they changed?
iii. How often does such engagement
occur? Has this changed since 1978? If
so, how has this changed?
iv. Does the amount, degree, or type
of issue discussed vary by issuer, or are
there consistent themes of discussion
and engagement? Has this changed since
1978? If so, how has this changed?
v. When do institutional investors
participate in the formulation,
determination, or direction of the basic
business decisions of issuers? Has this
changed since 1978? If so, how has it
changed?
b. How do index funds fit within the
portfolios of institutional investors?
Have index funds evolved since 1978?
If so, how have they evolved?
i. Why do intuitional investors choose
to create an index fund, exchangetraded fund, or the like? What are the
benefits and drawbacks of creating such
a fund?
ii. How does the acquisition of voting
securities held by an index fund,
exchange-traded fund, or the like occur?
Do acquirors use an algorithm or some
other automated mechanism to facilitate
acquisitions?
iii. Who oversees an index fund,
exchange-traded fund, or the like? Is
there one person or entity within an
investment organization tasked with
overseeing such a fund? More than one?
How often is it one versus more than
one?
4. How do institutional investors
manage holdings in the same issuer?
How has this changed since 1978?
a. Do institutional investors jointly
manage holdings in the same issuer? Do
they separately manage holdings in the
same issuer? Both? Has this changed
since 1978? If so, how has it changed?
b. How do institutional investors
make the decision to jointly or
separately manage holdings in the same
issuer? Has this changed since 1978? If
so, how has this changed?
c. Do answers to any of the above
questions depend on the type of issuer
or the type of institutional investor or
other factors? If so, what factors are
relevant? How does each factor
influence the actions of institutional
investors? Have the factors changed
since 1978? If so, how have they
changed?
5. How do institutional investors
apply the concept of solely for the
purpose of investment? Has this
PO 00000
Frm 00036
Fmt 4702
Sfmt 4702
77049
changed since 1978? If so, how has it
changed?
a. Do the entities listed in 16 CFR
802.64 currently hold the voting
securities of issuers solely for the
purpose of investment? How does this
differ from institutional investor
behavior in 1978? What significant
changes in institutional investor
behavior have occurred between 1978
and 2020?
b. What kinds of entities not listed in
16 CFR 802.64 currently hold the voting
securities of issuers solely for the
purpose of investment? How does the
current behavior of these entities differ
from their behavior in 1978?
c. If institutional investors make
certain acquisitions solely for the
purpose of investment and other
acquisitions not solely for the purpose
of investment, is it appropriate to
provide a status exemption for all of
their activities? If yes, why? If no, why
not?
d. Do institutional investors rely on
16 CFR 802.64 to exempt acquisitions in
or by index funds, exchange-traded
funds or the like? If so, how?
V. Influence Outside the Scope of
Voting Securities (16 CFR 801.1, 802.31)
The HSR Act applies to the
acquisition of assets and voting
securities. ‘‘The term voting securities
means any securities which at present
or upon conversion entitle the owner or
holder thereof to vote for the election of
directors of the issuer, or of an entity
included within the same person as the
issuer.’’ 20 The acquisition of a voting
security carries with it the right to
influence the business of a company
through the ability to vote for the
directors of that company, among other
things.
The Commission is aware, however,
that there are ways to gain influence
over a company without the acquisition
of the right to vote for the election of
directors inherent in voting securities.
For instance, the acquisition of
convertible voting securities or the use
of board observers could each result in
the ability to influence a company’s
business decisions. Currently, neither
the acquisition of convertible voting
securities nor rights to be a board
observer are reportable events under the
Act. The Commission, therefore, needs
to ascertain whether the acquisition and
exercise of these rights provide
opportunities to influence an issuer’s
business decisions, and thus should be
reportable events.
20 16
E:\FR\FM\01DEP1.SGM
CFR 801.1(f)(1)(i).
01DEP1
77050
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS10
A. Convertible Voting Securities (16 CFR
802.31)
The acquisition of convertible
debentures (convertible into common
stock), options, warrants, or preferred
shares, even with no present right to
vote for directors, may result in the
ability to influence the business of a
company. The Rules capture these kinds
of stakes in the concept of a convertible
voting security. ‘‘The term convertible
voting security means a voting security
which presently does not entitle its
owner or holder to vote for directors of
any entity.’’ 21 Section 802.31 exempts
the acquisition of convertible voting
securities.
The PNO has taken the informal
position that the acquisition of
convertible voting securities, when
accompanied by the right to designate or
appoint individuals to the board of
directors of the issuer equal to the
percentage of voting securities that
would be held upon conversion, is
reportable under the Act. The
Commission is considering revising
§ 802.31 to explicitly require
compliance with the HSR Act’s
reporting requirements when the
acquisition of convertible voting
securities is coincident with the
Acquiring Person having or obtaining
the right to designate or appoint any
individuals to the board of the issuer.
The Commission aims to understand the
potential benefits and burdens of such
a change through responses to the
following questions:
1. Is the acquisition of convertible
voting securities, when accompanied
with the right of appointment or
designation of individuals to the issuer’s
board of directors, equivalent to the
acquisition of voting securities with the
present right to vote for election of the
issuer’s board of directors? In what ways
are they the same and in what ways are
they different? What provisions could
accompany the right to appoint that
would make the acquisition the most
like an acquisition of voting securities?
What provisions make them different for
competition purposes? Have these
provisions changed since 1978? If so,
how have they changed?
2. Why would an Acquiring Person
choose one alternative over the other?
Have the benefits of one alternative over
another changed since 1978?
a. Is there a benefit of acquiring
convertible voting securities while
holding or obtaining the right to appoint
or designate individuals to an issuer’s
board of directors, as compared to the
acquisition of securities that have the
21 16
CFR 801.1(f)(2).
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
present right to vote? If so, what is the
benefit? Has the benefit changed since
1978? If so, how has it changed?
b. Under what situations does such a
benefit arise? Have these situations
changed since 1978? If so, how have
they changed?
3. What are the reasons the
Commission should or should not
require a filing whenever the acquirer of
convertible non-voting securities
receives a right to designate one or more
directors prior to conversion?
a. Should issuers that have
cumulative voting be subject to the same
requirements as issuers that do not have
cumulative voting? Why should they be
subject to different requirements? Is
there a difference in how much
influence an acquirer would have based
on whether the issuer has cumulative
voting? Why? How would the
Commission be able to distinguish when
it is a problem and when it is not?
4. What would be the burden
associated with this possible change?
a. Would the burden fall most on an
identifiable class of transactions? How
would such a change affect how an
identifiable class of transactions is
structured?
b. Would such a change introduce
significant inefficiencies into the market
for corporate control? What would be
the effect of that change in the market?
B. Board Observers
Another potential way to gain
influence over a company, beyond the
scope of acquiring voting securities, is
through board observers. The
Commission understands that it is
becoming increasingly common for
issuers and NCEs to include board
observers as part of their governance
structure. Issuers and NCEs often grant
rights to select and appoint board
observers to investors with significant
equity, in addition to or in lieu of
providing investors with board seats.
Even though board observers lack the
ability to vote on matters that come
before the issuer’s board, they may
nevertheless have significant influence
over the outcome of matters submitted
to the board for approval.22 At the very
least, board observers gain insight into
an issuer’s strategic decision-making,
which is not only useful to the investor
sponsoring the board observer, but may
also be useful to competitors in the
market, especially when those board
observers also serve as officers or
directors of a competitor.23 Companies
22 Obasi Investment Ltd. et al. v. Tibet
Pharmaceuticals, Inc. et al., 931 F.3d 179, 183 (3d
Cir. 2019).
23 See Complaint, In re Altria Group/JUUL Labs,
Dkt. 9383, ¶ 9, at https://www.ftc.gov/system/files/
PO 00000
Frm 00037
Fmt 4702
Sfmt 4702
likely benefit from interacting with
board observers because company
management can obtain additional
investor insight without having to alter
the composition or voting balance on
the board.
Given the opportunities that board
observers have to interact with
corporate officers, directors, and other
managers, and to gain access to
confidential information related to
strategic and operational decisions, the
Commission would like to better
understand the role of board observers.
In particular, the Commission would
like to know how investors might use
board observers’ rights to influence
competitive decision-making of issuers
and NCEs to ascertain whether the
acquisition of rights that provide
opportunities to wield this kind of
influence should be reportable under
the Act. To that end, the Commission
seeks responses to the following
questions:
1. What types of information are
available to an issuer/NCE board
observer?
a. With what frequency is a board
observer invited to all meetings? Is a
board observer always entitled to all
info provided to board members? Is a
board observer permitted to request
additional information beyond what is
presented at a board meeting? If so, with
what frequency?
b. Are board observers subject to any
restrictions on how they can use the
information they obtain in their capacity
as board observers? Are these
restrictions based on contract, bylaws or
regulations?
c. Do issuers/NCEs create formal
review processes for information
scheduled to be sent to a board
observer? If so, with what frequency?
Are outside counsel involved in
monitoring compliance? If so, with what
frequency?
d. Is the information scheduled to be
sent to a board observer subject to a
non-disclosure agreement that limits its
dissemination to others, including
officers and directors of competitors or
investors in competitors?
e. Do issuers/NCEs draft formal
guidance for their boards as to what
topics should not be discussed in the
presence of board observers? If so, with
what frequency? Are outside counsel
involved in monitoring compliance? If
so, with what frequency?
2. What means does an issuer/NCE
board observer have to influence board
policies or the strategic or operational
direction of the firm?
documents/cases/d09393_administrative_part_iii_
complaint-public_version.pdf.
E:\FR\FM\01DEP1.SGM
01DEP1
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS10
a. Does a board observer ever enjoy
any special right of notice or
consultation regarding major capital
expenditures or strategic decisions?
b. Does a board observer have access,
outside of board meetings, to managers
in the corporation, to investment
committee members in an NCE, or to
persons with similar decision-making
roles regarding the operations of the
business? If so, with what frequency?
c. Do board observers have the ability
to request a meeting of the issuer’s/
NCE’s board? If so, with what
frequency?
d. Do issuers/NCEs impose
restrictions on a board observer’s
speaking role during board meetings? If
so, with what frequency? How common
are ‘‘silent’’ board observers?
e. How frequently do board observers
move into senior executive roles at
issuers/NCEs?
3. What are the parameters of the
board observer role?
a. Is a board observer’s relationship
with the issuer/NCE always explicitly
defined in a written agreement between
the issuer and the investor? How
common are informal board observer
arrangements?
b. Are board observers (or those who
sponsor their observation of board
matters) covered by conflict of interest
rules or black-out periods such as those
that limit investments by board
members?
4. Are there any protocols on
selection/approval of board observers
and/or processes in place to ensure that
observers are not in a position to
facilitate sharing of competitively
sensitive information among
competitors?
5. For all of the questions above, do
rules or practices regarding board
observer rights to obtain confidential
information differ substantially between
issuers and NCEs? What factors account
for any such differences?
VI. Transactions or Devices for
Avoidance (16 CFR 801.90)
16 CFR 801.90 provides that the
Commission must disregard the
structure of transactions or devices used
by the parties for the purpose of
avoiding the HSR Act requirements and
review the substance of the transaction
as a whole to determine whether an
HSR filing is required. The PNO often
receives questions about whether
specific scenarios would be violations
under § 801.90, and the PNO has
occasionally offered informal staff
positions on § 801.90. For instance, the
PNO has an informal staff position that
says if a target makes a payout prior to
its acquisition in the form of an
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
extraordinary dividend, such a payment
would not trigger 16 CFR 801.90 if, as
a result of the dividend, the target no
longer meets the size of person test.24
The PNO’s informal staff position is
based on the idea that if an
extraordinary dividend reduces the
target’s cash on hand, it is unlikely to
present a 16 CFR 801.90 issue.
But there are situations where the
purpose of such a payout may be more
complicated. For instance, if the payout
involves more than the distribution of
cash on hand, this could present an
issue under 16 CFR 801.90. Each
issuance of an extraordinary dividend or
like payment must be carefully analyzed
to make sure that it is not a device for
avoidance under § 801.90. The
Commission has questions about
whether filing parties are engaging in
this analysis or, instead, assuming that
every extraordinary dividend is not a
device for avoidance under § 801.90. In
order to determine which are and are
not devices for avoidance, the
Commission would therefore like to
understand the mechanisms by which
targets engage in these and other kinds
of practices through responses to the
following questions:
1. What mechanisms do targets use to
pay out extraordinary dividends and
what are the reasons for such
dividends?
a. Is the focus on the reduction of cash
on hand or are there other motivations
for issuing such dividends? If so, what
are the other motivations?
b. Are there other ways of structuring
extraordinary dividends? If so, what are
they? If not, why not?
c. How often do targets issue
extraordinary dividends in advance of
being acquired? What are the reasons
that targets issue such dividends?
d. Is the buyer ever involved in the
target’s decision to issue an
extraordinary dividend in advance of an
acquisition? Why or why not?
2. Do targets use mechanisms other
than extraordinary dividends to reduce
cash on hand?
a. If so, what are they and how are
they structured? If not, why not?
b. Is the buyer involved? If yes, why
and with what frequency? If not, why
not?
3. What other actions should the
Commission scrutinize as possible
devices for avoidance?
VII. Filing Issues (16 CFR 802.21, 16
CFR Part 803 Appendix A and B)
The Commission has a strong interest
in an HSR filing process and an HSR
24 Am. Bar Ass’n., Premerger Notification Practice
Manual, Interpretation 96 (5th ed.).
PO 00000
Frm 00038
Fmt 4702
Sfmt 4702
77051
Form that garners competitively
significant information to assist the
Agencies in their review of transactions.
To that end, the Commission intends to
explore amending (a) the 16 CFR 802.21
five-year period during which a party
may acquire additional voting securities
without refiling, and (b) the requirement
in Item 8 of the HSR Form to disclose
certain prior acquisitions.
A. Acquisitions of Voting Securities
That Do Not Cross the Next Threshold
(16 CFR 802.21)
Under 16 CFR 802.21, filing parties
have five years from the end of the
waiting period to acquire additional
voting securities without making
another filing, as long as the additional
acquisitions do not exceed the next
threshold. For instance, Party A files to
cross the $100 million threshold (as
adjusted) on January 1 and receives
early termination on January 20, which
ends the waiting period. Party A then
has five years from January 20 to
continue to acquire voting securities of
the same issuer up to the next threshold,
in this case $500 million (as adjusted),
as long as it crosses the $100 million
threshold (as adjusted) within one year.
The time period in proposed § 802.21
was 180 days, but numerous comments
persuaded the Commission this time
period was too short.25 In the final rules,
the Commission chose a period of five
years, both as a result of these
comments and because it made sense to
correlate the timing of the exemption
with the timing of the Census and
resulting updated data.26 Given the
changes in worldwide economic activity
since 1978, Commission is now
concerned that the § 802.21 five-year
period may be too long. At the time of
the initial filing, the transaction may not
present competition concerns, but such
concerns could develop as a result of
changes in the lines of business of the
Acquiring Person and Acquired Person
during the five-year period, but those
changes would not require a new filing.
As a result, the Commission seeks to
understand the impact of shortening the
§ 802.21 five-year period through
responses to the following questions:
1. Have there been changes in
economic activity significant enough to
raise concerns that the Commission may
miss important competitive effects if it
does not shorten the five-year term?
2. If there are reasons to believe that
the § 802.21 five-year period is too long,
what period would address concerns
that additional acquisitions of the
Acquired Entity present competitive
25 43
FR 33450, 33493 (July 31, 1978).
26 Id.
E:\FR\FM\01DEP1.SGM
01DEP1
77052
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS10
concerns because the lines of business
of the Acquiring Person and/or
Acquired Person have changed? Why
would another period be more
appropriate?
3. Is there is a class of Acquiring
Persons for whom the decrease in the
exemption period would cause
significant burden? If not, why not? If
so, how?
B. Prior Acquisitions
When the Acquiring Person and the
Acquired Person report in the same or
‘‘overlapping’’ NAICS revenue code in
Item 5 of the HSR Form, the Acquiring
Person must report certain prior
acquisitions in Item 8: (1) The
acquisition of 50% or more of the voting
securities of an issuer or 50% or more
of non-corporate interests of an
unincorporated entity (subject to $10
million limitation) and (2) any
acquisition of assets valued at or above
the statutory size-of-transaction test at
the time of their acquisition. Item 8
limits the Acquiring Person’s disclosure
to those acquisitions within the
overlapping NAICS code over the last
five years.
The Commission is concerned that
Item 8 does not capture all
competitively significant acquisitions.
There are several reasons why this
might be the case. For instance, the
Acquiring Person does not have to
disclose prior acquisitions when it and
the Acquired Person report revenue in
different NAICS codes. Nevertheless,
overlapping NAICS codes are imperfect
predictors of whether the acquisition
presents competitive concerns that need
review. For instance, an Acquiring
Person is not subject to the disclosure
requirement if a prior acquisition
involved a potential competitor with no
revenue in an overlapping NAICS code
at the time of the acquisition. Similarly,
an Acquiring Person need not disclose
a prior acquisition that involved a
vertical relationship when companies at
different levels of the distribution chain
report in different NAICS codes. As a
result, the Commission is considering
eliminating the overlapping NAICS code
limitation in Item 8 so that the
Acquiring Person would have to list all
its acquisitions of 50% or more of the
voting securities of an issuer or 50% or
more of non-corporate interests of an
unincorporated entity (subject to the
$10 million limitation) and any
acquisition of assets valued at or above
the statutory size-of-transaction test at
the time of their acquisition in the five
years prior to filing. The Commission
seeks comment on this potential change
through responses to the following
questions:
VerDate Sep<11>2014
18:39 Nov 30, 2020
Jkt 253001
1. What would be the benefit or
burden associated with this possible
change? Are there any classes of
transactions for which the benefit or
burden would be greater? If there are
classes of transactions for which the
benefit is greater, why is the benefit
greater? If there are classes of
transactions for which the burden is
greater, why is the burden greater?
2. Is there any way to distinguish
prior acquisitions that might have
competitive significance from those that
do not, such that the Commission would
not need to require a list of all prior
acquisitions?
In addition to the topics outlined
above, commenters are welcome to
provide input on any other HSR Rule.
As part of that input, identify the
changes in investor behavior or
competitive dynamics that would justify
a change in the Commission’s current
approach.
By direction of the Commission.
April Tabor,
Acting Secretary.
Statement of Commissioner Rohit Chopra
September 21, 2020.
Summary
• Premerger notification is a critical data
source, but the Commission faces enormous
information gaps when seeking to detect and
halt anticompetitive transactions.
• While the proposed rule closes a
loophole when it comes to investment
manager holdings, the proposed approach to
exempt a wide swath of minority stakes is
concerning and adds to existing information
gaps.
• The Commission needs to update the
treatment of certain debt transactions when
determining deal size for the purpose of
premerger notification. The current approach
allows dealmakers to structure
anticompetitive transactions in ways that can
go unreported.
In September 1976, Congress gave the
Federal Trade Commission an important tool
enabling it to block harmful mergers. The
Hart-Scott-Rodino Antitrust Improvements
Act of 1976 (‘‘HSR Act’’) requires prior
notification to the antitrust agencies in
advance of closing certain mergers and
acquisitions.1
Prior to the HSR Act’s enactment,
companies could quickly ‘‘scramble the eggs’’
of assets and operations, or even shut down
functions. This made it extremely difficult
for the antitrust agencies to remedy
competitive harms through divestitures of
assets. Years of protracted litigation to stop
further damage and distortions were often the
result.2
The HSR Act fundamentally changed the
process of merger review by giving the
Act section 7A, 15 U.S.C. 18a.
example, in United States v. El Paso Natural
Gas Co., 376 U.S. 651 (1964), it took seventeen
years of litigation before a divestiture finally took
place.
antitrust agencies time to halt
anticompetitive transactions before these
deals closed. Today, the FTC focuses a
substantial portion of its competition mission
on investigating and challenging mergers
reported under the HSR Act. Importantly,
only a small set of transactions—the ones
with the highest valuations—are subject to
premerger notification. The HSR Act
specifies the valuation threshold, currently
set at $94 million, which is typically adjusted
upward each year. Since there are many ways
to determine a deal’s valuation, Congress
gave the FTC broad authority to implement
rules so that buyers know if they need to
report their transactions and what they are
required to submit with their filing. The
Commission can also exempt classes of
transactions and tailor filing requirements.
While premerger notification filings
provide the Commission with certain
nonpublic information,3 gathering and
analyzing market intelligence on transaction
activity and competitive dynamics is a major
challenge. We need to continuously assess
how we can enhance our market monitoring
techniques and evolve our analytical
approaches.
Today, the Commission is soliciting
comment on two rulemakings regarding our
policies to implement the HSR Act’s
premerger notification protocols. The first
publication, a Notice of Proposed
Rulemaking, proposes specific rules and
exemptions. While some of the proposals are
helpful improvements, I respectfully disagree
with our approach to exempting a broad
swath of transactions from reporting. The
second publication, an Advance Notice of
Proposed Rulemaking, requests comment on
a broad range of topics to set the stage for
modernizing the premerger notification
program to align with market realities. I
support soliciting input to rethink our
approach. I discuss each of these rulemakings
below.
Notice of Proposed Rulemaking
The Notice of Proposed Rulemaking
outlines specific amendments that the
Commission is proposing to the HSR rules.
The aggregation and exemption provisions
are particularly noteworthy. The aggregation
provisions are worthwhile, since they close
a loophole and align with market realities.
However, I am concerned about the
exemption provisions, since we will
completely lose visibility into a large set of
transactions involving non-controlling stakes.
Aggregation Provisions
The financial services industry is well
known for using an alphabet soup of small
entities, like shell companies, partnerships,
and other investment vehicles, to structure
deals. Even though they may be under
common management by the same person or
group, like a private equity fund or a hedge
fund, these smaller legal entities are all
treated separately under the existing rules.
The proposed aggregation provisions will
help to prevent acquirers from splitting up
1 Clayton
2 For
PO 00000
Frm 00039
Fmt 4702
Sfmt 4702
3 I agree with Commissioner Slaughter that
current filing requirements, including for minority
stakes, can have the beneficial effect of deterring
certain anticompetitive transactions.
E:\FR\FM\01DEP1.SGM
01DEP1
Federal Register / Vol. 85, No. 231 / Tuesday, December 1, 2020 / Proposed Rules
transactions into small slices across multiple
investment vehicles under their control to
avoid reporting. The proposal would require
investors and other buyers to add together
their stakes across commonly managed funds
to determine whether they need to report a
transaction.
Exemption Provisions
By creating a reporting threshold based on
the value of a transaction, the law already
exempts most transactions from agency
review. Because of this, it is difficult to
systematically track these transactions, and
even harder to detect and deter those that are
anticompetitive.
Now, the FTC is proposing to widen that
information gap by creating a new exemption
for minority stakes of 10% or less, subject to
certain conditions. Importantly, the proposal
is not exempting specific aspects of the
reporting requirements—it is a total
exemption, so the agency will receive no
information whatsoever from the buyer or the
seller that the transaction even occurred.
This adds to the burdens and information
asymmetries that the agency already faces
when it comes to detecting potentially
harmful transactions.4
Companies and investors purchase
minority, non-controlling stakes in a firm for
a number of reasons. Sometimes, buyers
might start with a minority stake, with the
goal—or even with a contractual option—of
an outright takeover as they learn more about
the company’s operations. Even though they
might have a small stake, they can exert
outsized control. In other cases, buyers might
look for minority stakes in multiple,
competing firms within a sector or industry,
and some or all of these acquisitions may fall
below the reporting thresholds. Of course, if
they are able to obtain seats on boards of
directors of competing companies, this can
be illegal.
Investors and buyers can only use the
proposed exemption if they do not currently
own stakes in firms that compete or do
business with the company they plan to
acquire. Since many investors might not
know about the specific business dealings
across companies, this may be difficult to
enforce and puts more burden on the agency.
Even if one believes that transactions
involving a minority stake are less likely to
be illegal, there are many potential
alternatives to outright elimination of
reporting. Unfortunately, the rulemaking
does not outline alternative approaches (such
as tailored, simplified filing requirements or
shortened waiting periods) for minority
stakes.
khammond on DSKJM1Z7X2PROD with PROPOSALS10
Advance Notice of Proposed Rulemaking
As markets evolve, it is important that the
HSR Act and its implementing rules reflect
4 The FTC may not be able to rely on other
sources of robust data required by other agencies.
For example, the Securities and Exchange
Commission has proposed eliminating reporting for
thousands of registered investment funds that
previously detailed their holdings to the public. See
Statement of SEC Comm’r Allison Herren Lee
Regarding Proposal to Substantially Reduce 13F
Reporting (July 10, 2020), https://www.sec.gov/
news/public-statement/lee-13f-reporting-2020-0710.
VerDate Sep<11>2014
16:58 Nov 30, 2020
Jkt 253001
those developments. The Advance Notice of
Proposed Rulemaking seeks input on a wide
array of market-based issues that may affect
the Commission’s merger oversight. One
topic of particular interest is whether to
include debt as part of the valuation of a
transaction. Since the HSR Act’s passage,
corporate debt markets have grown in
importance for companies competing in
developed economies. Many major deals
involve vast sums of borrowed money.
However, the Commission has not formally
codified a view on the treatment of certain
debt transactions. Instead, existing staff
guidance excludes many debt transactions
from the deal’s overall value. This is
worrisome, since it means that many
potentially anticompetitive transactions can
go unreported, since they may fall below the
size threshold. In addition, this view has
been provided informally, communicated
through unofficial interpretations outside of
formal rules or guidance. It will be important
to take steps to collect input and codify the
Commission’s policies on valuation,
particularly with respect to the treatment of
debt, since formal guidance or rules will offer
clarity and will be easier to enforce.
The Advance Notice of Proposed
Rulemaking also seeks information that will
lay groundwork for broader reforms to our
premerger notification program. I look
forward to the data and written submissions
to this document.
Conclusion
Adequate premerger reporting is a helpful
tool used to halt anticompetitive transactions
before too much damage is done. However,
the usefulness of the HSR Act only goes so
far. This is because many deals can quietly
close without any notification and reporting,
since only transactions above a certain size
are reportable.5 The FTC ends up missing a
large number of anticompetitive mergers
every year. In addition, since amendments to
the HSR Act in 2000 raised the size
thresholds on an annual basis, the number of
HSR-reportable transactions has decreased.
I want to commend agency staff for their
work in identifying potential blind spots in
the premerger reporting regime. I also want
to thank state legislatures and state attorneys
general for enacting and implementing their
own premerger notification laws to fill in
some of these gaps. For example, a new law
in State of Washington has taken effect,
which requires advance notice of any
transactions in the health care sector, where
many problematic mergers fall below the
radar.6
5 Small transactions can be just as harmful to
competition as large transactions notified under the
HSR Act. For example, ‘‘catch and kill’’ acquisitions
of an upstart competitor in fast-moving markets can
be particularly destructive. In addition, ‘‘roll-ups,’’
an acquisition strategy involving a series of
acquisitions of small players to combine into a
larger one, can have very significant negative effects
on competition. See Statement of Fed. Trade
Comm’r Rohit Chopra Regarding Private Equity
Roll-ups and the Hart-Scott Rodino Annual Report
to Congress, Comm’n File No. P110014 (July 8,
2020), https://www.ftc.gov/system/files/documents/
public_statements/1577783/p110014hsrannual
reportchoprastatement.pdf.
6 See Healthcare Transaction Notification
Requirement, WASH. STATE OFF. OF THE ATT’Y
PO 00000
Frm 00040
Fmt 4702
Sfmt 4702
77053
As we conduct this examination of the
HSR Act, we should identify areas where
laws may need to be changed or updated,
especially when we cannot fill those gaps
through amendments to our rules. For
example, we may need to pursue reforms to
ensure that ‘‘roll ups’’ are reported, where a
buyer might acquire a large number of small
companies that may not be individually
reportable. We may also need to look
carefully at the length of the waiting period,
to determine if it is long enough to conduct
a thorough investigation. I look forward to
reviewing the input to these two
rulemakings, so that our approach reflects
market realities.
[FR Doc. 2020–21754 Filed 11–30–20; 8:45 am]
BILLING CODE 6750–01–P
FEDERAL TRADE COMMISSION
16 CFR Parts 801, 802 and 803
RIN 3084–AB46
Premerger Notification; Reporting and
Waiting Period Requirements
Federal Trade Commission.
Notice of proposed rulemaking.
AGENCY:
ACTION:
The Federal Trade
Commission (‘‘FTC’’ or ‘‘Commission’’)
is proposing amendments to the
premerger notification rules (‘‘the
Rules’’) that implement the Hart-ScottRodino Antitrust Improvements Act
(‘‘the Act’’ or ‘‘HSR’’) to change the
definition of ‘‘person’’ and create a new
exemption. The Commission also
proposes explanatory and ministerial
changes to the Rules, as well as
necessary amendments to the HSR Form
and Instructions to effect the proposed
changes.
DATES: Comments must be received on
or before February 1, 2021.
ADDRESSES: Interested parties may file a
comment online or on paper by
following the instructions in the
Invitation to Comment part of the
SUPPLEMENTARY INFORMATION section
below. Write ‘‘16 CFR parts 801–803:
Hart-Scott-Rodino Coverage, Exemption,
and Transmittal Rules; Project No.
P110014’’ on your comment. File your
comment online at https://
www.regulations.gov by following the
instructions on the web-based form. If
you prefer to file your comment on
paper, mail your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW, Suite
CC–5610 (Annex J), Washington, DC
20580, or deliver your comment to the
SUMMARY:
GEN. (last visited Sept. 16, 2020), https://
www.atg.wa.gov/healthcare-transactionsnotification-requirement; see also S.H.B. 1607, 66th
Leg., Reg. Sess. (Wash. 2019).
E:\FR\FM\01DEP1.SGM
01DEP1
Agencies
[Federal Register Volume 85, Number 231 (Tuesday, December 1, 2020)]
[Proposed Rules]
[Pages 77042-77053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21754]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
16 CFR Parts 801, 802 and 803
RIN 3084-AB46
Premerger Notification; Reporting and Waiting Period Requirements
AGENCY: Federal Trade Commission.
ACTION: Advance notice of proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Federal Trade Commission (``FTC'' or ``Commission'') is
issuing this advance notice of proposed rulemaking (``ANPRM'') to
gather information, related to seven topics, that will help to
determine the path for future amendments to the premerger notification
rules (``the Rules'') under the Hart-Scott-Rodino Antitrust
Improvements Act (``the Act'' or ``HSR'').
DATES: Comments must be received on or before February 1, 2021.
ADDRESSES: Interested parties may file a comment online or on paper, by
following the instructions in the Invitation to Comment part of the
SUPPLEMENTARY INFORMATION section below. Write ``16 CFR parts 801-803:
Hart-Scott-Rodino Rules ANPRM, Project No. P110014'' on your comment.
File your comment online at https://www.regulations.gov by following
the instructions on the web-based form. If you prefer to file your
comment on paper, mail your comment to the following address: Federal
Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW,
Suite CC-5610, (Annex J), Washington, DC 20580, or deliver your comment
to the following address: Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite
5610 (Annex J), Washington, DC 20024.
FOR FURTHER INFORMATION CONTACT: Robert Jones (202-326-3100), Assistant
Director, Premerger Notification Office, Bureau of Competition, Federal
Trade Commission, 400 7th Street SW, Room CC-5301, Washington, DC
20024.
SUPPLEMENTARY INFORMATION:
Invitation to Comment
You can file a comment online or on paper. For the Commission to
consider your comment, we must receive it on or before February 1,
2021. Write ``16 CFR parts 801-803: Hart-Scott-Rodino Rules ANPRM,
Project No. P110014'' on your comment. Your comment--including your
name and your state--will be placed on the public record of this
proceeding, including, to the extent practicable, on the https://www.regulations.gov website.
Because of the public health emergency in response to the COVID-19
outbreak and the agency's heightened security screening, postal mail
addressed to the Commission will be subject to delay. We strongly
encourage you to submit your comment online through the https://www.regulations.gov website. To ensure the Commission considers your
online comment, please follow the instructions on the web-based form.
If you file your comment on paper, write ``16 CFR parts 801-803:
Hart-Scott-Rodino Rules ANPRM, Project No. P110014'' on your comment
and on the envelope, and mail your comment to the following address:
Federal Trade Commission, Office of the Secretary, 600 Pennsylvania
Avenue NW, Suite CC-5610, (Annex J), Washington, DC 20580, or deliver
your comment to the following address: Federal Trade Commission, Office
of the Secretary, Constitution Center, 400 7th Street SW, 5th Floor,
Suite 5610 (Annex J), Washington, DC 20024. If possible, please submit
your paper comment to the Commission by courier or overnight service.
Because your comment will be placed on the publicly accessible
website, https://www.regulations.gov, you are solely responsible for
making sure your comment does not include any sensitive or confidential
information. In particular, your comment should not include sensitive
personal information, such as your or anyone else's Social Security
number; date of birth; driver's license number or other state
identification number, or foreign country equivalent; passport number;
financial account number; or credit or debit card number. You are also
solely responsible for making sure your comment does not include any
sensitive health information, such as medical records or other
individually identifiable health information. In addition, your comment
should not include any ``trade secret or any commercial or financial
information which . . . is privileged or confidential,''--as provided
by Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule
4.10(a)(2), 16 CFR 4.10(a)(2)--including in particular competitively
sensitive information such as costs, sales statistics, inventories,
formulas, patterns, devices, manufacturing processes, or customer
names.
Comments containing material for which confidential treatment is
requested must be filed in paper form, must be clearly labeled
``Confidential,'' and must comply with FTC Rule 4.9(c). In particular,
the written request for confidential treatment that accompanies
[[Page 77043]]
the comment must include the factual and legal basis for the request,
and must identify the specific portions of the comment to be withheld
from the public record. See FTC Rule 4.9(c). Your comment will be kept
confidential only if the FTC General Counsel grants your request in
accordance with the law and the public interest. Once your comment has
been posted publicly at www.regulations.gov--as legally required by FTC
Rule 4.9(b)--we cannot redact or remove your comment, unless you submit
a confidentiality request that meets the requirements for such
treatment under FTC Rule 4.9(c), and the General Counsel grants that
request.
Visit the FTC website to read this document and the news release
describing it. The FTC Act and other laws that the Commission
administers permit the collection of public comments to consider and
use in this proceeding as appropriate. The Commission will consider all
timely and responsive public comments it receives on or before February
1, 2021. For information on the Commission's privacy policy, including
routine uses permitted by the Privacy Act, see https://www.ftc.gov/site-information/privacy-policy.
Overview
The Act and Rules require the parties to certain mergers and
acquisitions to file notifications with the Commission and the
Assistant Attorney General in charge of the Antitrust Division of the
Department of Justice (``the Assistant Attorney General'')
(collectively, ``the Agencies'') and to wait a specified period of time
before consummating such transactions. The reporting and waiting period
requirements are intended to enable the Agencies to determine whether
proposed mergers or acquisitions may violate the antitrust laws if
consummated and, when appropriate, to seek injunctions in federal court
to prohibit anticompetitive transactions prior to consummation.
Section 7A(d)(1) of the Clayton Act, 15 U.S.C. 18a(d)(1), directs
the Commission, with the concurrence of the Assistant Attorney General,
in accordance with the Administrative Procedure Act, 5 U.S.C. 553, to
require that premerger notification be in such form and contain such
information and documentary material as may be necessary and
appropriate to determine whether the proposed transaction may, if
consummated, violate the antitrust laws. In addition, Section 7A(d)(2)
of the Clayton Act, 15 U.S.C. 18a(d)(2), grants the Commission, with
the concurrence of the Assistant Attorney General, in accordance with 5
U.S.C. 553, the authority to define the terms used in the Act, exempt
classes of transactions that are not likely to violate the antitrust
laws, and prescribe such other rules as may be necessary and
appropriate to carry out the purposes of Section 7A.
Since the enactment of the Act, the Commission has updated and
refined the Rules many times. Indeed, the Agencies have a strong
interest in making sure the Rules are as current and relevant as
possible. Certain rules interpreting and implementing the Act, some of
which have not been changed since they were first promulgated in 1978,
may need additional updating. In this ANPRM, the Commission proposes to
gather information on seven topics to help determine the path for
potential future amendments to numerous provisions of Parts 801, 802,
and 803 of the Rules under the Act.
Background
Although it regularly reviews the Rules and revises them on a
rolling basis, the Commission is issuing this ANPRM to solicit
information to support review of the Rules on a more unified basis as
part of its systematic review of all FTC rules and guides. The
Commission is aware that market and business practices are constantly
evolving, and that these changes make it especially important to
evaluate whether the Rules are still serving their intended purpose or
if they need to be amended, eliminated, or supplemented.
To accomplish this, the Commission is publishing in this ANPRM a
number of questions related to seven different topics about which
questions frequently arise in discussions of the Rules: Size of
Transaction, Real Estate Investment Trusts, Non-Corporate Entities,
Acquisitions of Small Amounts of Voting Securities, Influence outside
the Scope of Voting Securities, Devices for Avoidance, and Filing
Issues. Answers to questions on these topics will provide information
that may facilitate drafting of new or revised rules.
The Commission welcomes comments on all of these topics, or on any
sub-topic within them. The Commission, however, does not expect that
every commenter will address all seven topics, or even every question
relating to each topic. The Commission notes that comments it receives
in response to this ANPRM may also inform the Notice of Proposed
Rulemaking regarding the proposed change in the Sec. 801.1(a)(1)
definition of ``person'' and proposed exemption Sec. 802.15 published
in the Federal Register at the same time as this ANPRM.
I. Size of Transaction
Section 7A(a)(2) of the Clayton Act mandates an HSR filing when a
transaction meets the Size of Transaction (``SOT'') test, subject to
other provisions of the Rules, including exemptions.\1\ To determine
whether a transaction meets the SOT test, filing parties must look to
Acquisition Price (``Acquisition Price'') under 16 CFR 801.10 or, in
some cases, Fair Market Value (``FMV'') under 16 CFR 801.10(c)(3). As
it is the filing parties' responsibility to conduct these calculations,
the Commission would benefit from additional information on how filing
parties engage in the calculation for both Acquisition Price and FMV.
---------------------------------------------------------------------------
\1\ Steps for Determining Whether an HSR Filing is Required,
FTC.GOV, https://www.ftc.gov/enforcement/premerger-notification-program/hsr-resources/steps-determining-whether-hsr-filing (last
visited July 07, 2020).
---------------------------------------------------------------------------
A. Acquisition Price (16 CFR 801.10)
Under 16 CFR 801.10(c)(2), the Acquisition Price ``shall include
the value of all consideration for such voting securities, non-
corporate interests, or assets to be acquired.'' \2\ The FTC's
Premerger Notification Office (``the PNO'') has long taken the position
that, when a transaction has a determined Acquisition Price, debt may
be excluded from the Acquisition Price in certain circumstances. For
example, if a buyer pays off a target's debt as part of the
transaction, the buyer may deduct the amount of the retired debt from
the Acquisition Price. This position dates from the earliest days of
interpreting the HSR Rules in the late 1970s and early 1980s and is
based, in part, on the analysis of a target's balance sheet liabilities
in the context of an acquisition of voting securities.
---------------------------------------------------------------------------
\2\ 16 CFR 801.10(c)(2).
---------------------------------------------------------------------------
The PNO has also allowed the deduction of certain expenses when
calculating the Acquisition Price. For example, where the purchase
price in the parties' transaction agreement includes funds earmarked to
pay off the seller's transaction expenses, the PNO has permitted the
parties to deduct that amount when calculating the Acquisition Price
based on the view that such payments do not reflect consideration for
the target.
The Commission is aware that these informal PNO staff positions can
have a significant impact on the calculation of the Acquisition Price
and, in turn, on whether a transaction is reportable under the Act.
Given the potential for these positions to affect the structure of a
transaction, the Commission believes
[[Page 77044]]
these informal PNO staff positions may need revision. As a result, the
Commission aims to understand the decision-making involved in the
deduction of retired debt or other amounts or categories of expenses
from the Acquisition Price through responses to the following
questions:
1. When negotiating a transaction, does a buyer ever offer to pay
off or retire debt as part of the deal? Under what circumstances? How
have these circumstances evolved since the late 1970s/early 1980s?
a. Why might a buyer offer to pay off or retire debt as part of the
deal now as opposed to in the late 1970s/early 1980s? Have the
competitive implications of the deal ever been a factor in this
decision?
b. Why might a buyer decline to pay off or retire debt as part of
the deal now as opposed to in the late 1970s/early 1980s? Have the
competitive implications of the deal ever been a factor in this
decision?
c. Does a seller prefer a buyer that is willing to pay off or
retire debt as part of the deal? Why or why not? Are seller preferences
different now than in the late 1970s/early 1980s?
d. In a multiple bid situation, is a buyer's willingness to pay off
or retire debt as part of the deal ever a factor in the seller's
selection of the winning bid? Was it a factor in the late 1970s/early
1980s? And if it is evaluated differently today versus the 1970s/early
1980s, why is it evaluated differently?
e. Do sellers ever reject a buyer's offer to pay off or retire debt
as part of the deal? Under what circumstances? How have these
circumstances evolved since the late 1970s/early 1980s? Have the
competitive implications of the deal ever been a factor in this
decision?
f. Are there any limitations (legal or otherwise) on a buyer's
ability to pay off or retire debt as part of the deal? If so, what are
they? How do these limitations differ from limitations in place in the
late 1970s/early 1980s?
g. Are buyers more or less likely to pay off or retire debt as part
of the deal now than they were in the late 1970s/early 1980s? Why or
why not?
2. When negotiating a transaction, does a buyer ever offer to pay
other expenses of or within the seller (e.g., legal or banking fees,
change of control payments, etc.) as part of the deal? Under what
circumstances? How have these circumstances evolved since the late
1970s/early 1980s?
a. Why might a buyer offer to pay such expenses as part of the deal
now as opposed to in the late 1970s/early 1980s? Have the competitive
implications of the deal ever been a factor in this decision?
b. Why might a buyer decline to pay such expenses as part of the
deal now as opposed to in the late 1970s/early 1980s? Have the
competitive implications of the deal ever been a factor in this
decision?
c. Does a seller prefer a buyer that is willing to pay such
expenses as part of the deal? Why or why not? Are seller preferences
different now than in the late 1970s/early 1980s?
d. In a multiple bid situation, is a buyer's willingness to pay
such expenses as part of the deal ever a factor in the seller's
selection of the winning bid? Was it a factor in the late 1970s/early
1980s? If it is evaluated differently today versus the 1970s/early
1980s, why is it evaluated differently?
e. Do sellers ever reject a buyer's offer to pay such expenses as
part of the deal? Under what circumstances? How have these
circumstances evolved since the late 1970s/early 1980s? Have the
competitive implications of the deal ever been a factor in this
decision?
f. Are there any limitations (legal or otherwise) on a buyer's
ability to pay such expenses as part of the deal? If so, what are they?
Do these limitations differ from limitations in place in the late
1970s/early 1980s? If they differ, how do they differ?
g. Are buyers more or less likely to pay such expenses as part of
the deal now than they were in the late 1970s/early 1980s? Why or why
not?
3. How do parties currently calculate the Acquisition Price? How
has the calculation changed since the late 1970s/early 1980s?
a. Under what conditions is the Acquisition Price different from
the purchase price or consideration identified in the transaction
agreement? Have these conditions changed since the late 1970s/early
1980s? If they have changed, how have they changed?
b. Do transaction agreements ever lack a firm or certain purchase
price? Under what conditions? Have these conditions changed since the
late 1970s/early 1980s? If they have changed, how have they changed?
i. Why would parties negotiate a deal without a firm or certain
purchase price? What factors have affected such a decision or deal
structure? Have these factors evolved since the late 1970s/early 1980s?
If they have changed, how have they changed? Have the competitive
implications of the deal ever been a factor in this negotiating a deal
without a firm or certain purchase price?
ii. What are the limits on the scope of the undetermined payments
or deductions? Have these limits changed since the late 1970s/early
1980s? If they have changed, how have they changed?
c. Can an Acquisition Price be subject to undeterminable deductions
or deductions of undeterminable value? Under what conditions? Have
these conditions evolved since the late 1970s/early 1980s? If they have
changed, how have they changed? What are some examples of each kind of
deduction and how have they changed since the late 1970s/early 1980s?
d. Are there certain categories of consideration that are commonly
deducted or added when calculating the Acquisition Price? Have these
categories changed since the late 1970s/early 1980s? If they have
changed, how have they changed?
e. Is the ultimate recipient of a payment ever a factor in whether
such payment is included when calculating the Acquisition Price? Why or
why not? In what circumstances? Has this determination changed since
the late 1970s/early 1980s? If it has changed, how has it changed?
f. Is employee compensation (e.g., bonus payments, retention
payments, payments for contingent employee compensation) ever included
when calculating the Acquisition Price? Why or why not? In what
circumstances? Has this determination changed since the late 1970s/
early 1980s? If it has changed, how has it changed?
g. Does the form of employee compensation affect whether it is
included in the Acquisition Price? Under what circumstances? Has this
determination changed since the late 1970s/early 1980s? If it has
changed, how has it changed?
h. Is the value of employee compensation ever deducted from the
Acquisition Price? Why or why not? Under what circumstances? Has this
determination changed since the late 1970s/early 1980s? If it has
changed, how has it changed?
i. Is there a ``control premium'' associated with the acquisition
of control? How does an Acquiring Person determine that ``control
premium''? Has this determination changed since the late 1970s/early
1980s? If it has changed, how has it changed?
4. When calculating the Acquisition Price, do parties include all
consideration paid for the target? How has this approach changed since
the late 1970s/early 1980s?
a. How do parties define ``consideration?'' Has this changed since
the late 1970s/early 1980s? If it has changed, how has it changed?
b. Do parties rely on a standard legal definition for
``consideration?'' If so,
[[Page 77045]]
what is it and from what is it derived? Has this changed since the late
1970s/early 1980s? If it has changed, how has it changed?
c. Is consideration defined any differently for the purposes of
calculating Acquisition Price than it is for non-HSR purposes? Why or
why not? Has this changed since the late 1970s/early 1980s? If it has
changed, how has it changed?
d. Are any categories of payments excluded from the above
definition of ``consideration?'' Why or why not? Has this changed since
the late 1970s/early 1980s? If it has changed, how has it changed?
e. Is the ultimate recipient of the payment ever a factor in
whether such payment is included as consideration? Why or why not? Has
this changed since the late 1970s/early 1980s? If it has changed, how
has it changed?
5. When calculating the Acquisition Price, how does debt affect the
calculation? How has this approach changed since the late 1970s/early
1980s?
a. Does the debt reported on the target's balance sheet affect the
calculation of the Acquisition Price? Why or why not? In what
circumstances? Should it? Why or why not? Has this changed since the
late 1970s/early 1980s? If it has changed, how has it changed?
b. Does the buyer's pay off or retirement of debt affect the
calculation of the Acquisition Price? Why or why not? In what
circumstances? Should it? Why or why not? Has this changed since the
late 1970s/early 1980s? If it has changed, how has it changed?
c. Does the treatment of debt (either reported on a balance sheet
or being paid off or retired by the buyer) differ based on whether the
acquisition is of (1) voting securities, (2) non-corporate interests,
or (3) assets? Why or why not? Should it? Why or why not? Has this
changed since the late 1970s/early 1980s? If it has changed, how has it
changed?
d. Should the calculation of Acquisition Price focus on the total
amount paid by the Acquiring Person (including debt that is paid off or
retired) or the net amount received by the Acquired Person (excluding
debt that is paid off or retired)? Why? Has this changed since the late
1970s and early 1980s? If it has changed, how has it changed?
6. Where an acquisition is of voting and non-voting securities, how
is the Acquisition Price allocated between the voting securities and
the non-voting securities? How has this approach changed since the late
1970s/early 1980s?
a. Are the voting securities and non-voting securities separately
valued? Why or why not? Has this changed since the late 1970s/early
1980s? If it has changed, how has it changed?
b. Are each of the voting securities and the non-voting securities
valued? Why or why not? Has this changed since the late 1970s and early
1980s? If it has changed, how has it changed?
B. Fair Market Value (16 CFR 801.10(c)(3))
Sometimes a transaction does not have a determined Acquisition
Price. This is often due to the fluctuation in stock prices or the
inability to calculate the exact amount of contingent future payments.
As a result, the Fair Market Value (``FMV'') of the transaction becomes
critical to determining reportability under the Act.
Per Sec. 801.10(c)(3), FMV ``shall be determined in good faith by
the board of directors of the ultimate parent entity included within
the Acquiring Person, or, if unincorporated, by officials exercising
similar functions; or by an entity delegated that function by such
board or officials.'' Once the Acquiring Person, or its delegate, has
determined the FMV, there is no requirement to share with the Agencies
the details of how that FMV was determined. The Commission would like
to understand better the determination of FMV through responses to the
following questions:
1. When an Acquiring Person is evaluating the potential acquisition
of voting securities, non-corporate interests, or assets, what
methodologies does that Acquiring Person use to support valuation in
the ordinary course of due diligence and negotiation of the
acquisition? How have these methodologies changed since the late 1970s/
early 1980s?
a. If an acquisition involves the acquisition of non-voting
securities, what methodologies does the Acquiring Person use to value
the non-voting securities? Have these methodologies changed since the
late 1970s/early 1980s? If they have changed, how have they changed?
b. In an acquisition of both voting securities and non-voting
securities, does the Acquiring Person ever use one methodology to value
the voting securities and a different methodology to value the non-
voting securities? Why or why not? Have these methodologies changed
since the late 1970s/early 1980s? If they have changed, how have they
changed?
c. Where the Acquiring Person receives board appointment or board
designation rights (or their non-corporate equivalent) in conjunction
with the acquisition of voting (or non-voting) securities, do those
rights affect the FMV of the voting (or non-voting) securities
acquired? Has this changed since the late 1970s/early 1980s? If this
has changed, how has it changed?
2. How does the determination of FMV under 16 CFR 801.10(c)(3)
differ from the Acquiring Person's determination of value in the
ordinary course of due diligence and negotiation of an acquisition? How
has this determination changed since the late 1970s/early 1980s?
a. What factors go into determining FMV? Do these factors vary by
industry, type of acquisition (asset, non-corporate interest,
intellectual property), size of the target, or for other reasons?
Describe each of the ways these factors vary and how each one varies.
How have these factors changed since the late 1970s/early 1980s? Are
there difficulties involved in performing FMV analyses? If so, what are
those difficulties? Have these difficulties changed since the late
1970s/early 1980s? If they have changed, how have they changed? What
additional guidance, if any, might the Commission provide to eliminate
these difficulties?
b. How often and for what purposes do boards of directors rely on
third-party bankers and other appraisers to provide FMV analysis? Do
boards of directors evaluate the accuracy of those results compared to
their own calculations? If so, how does the board of directors evaluate
the accuracy of those results? Has this process changed since the late
1970s/early 1980s? If it has changed, how has it changed?
c. Should the Commission require an independent FMV analysis for
some transactions to ensure consistency with standard valuation
practices? If so, for what type of transactions should the Commission
require independent FMV analysis? If the Commission requires an
independent analysis, who should conduct the FMV analysis?
3. When calculating the FMV because the Acquisition Price is not
determined as a result of future or uncertain payments, what financial
or valuation concepts are used to determine the value of those future
or uncertain payments? Have these concepts changed since the late
1970s/early 1980s? If they have changed, how have they changed?
4. How does an Acquiring Person determine the present FMV of assets
that are not yet commercialized? For example, how does an Acquiring
Person determine the present FMV of
[[Page 77046]]
intellectual property surrounding a product that currently is under
development? Has this determination changed since the late 1970s/early
1980s? If it has changed, how has it changed?
5. In determining the FMV, how does the Acquiring Person account
for the value of any assumed liabilities (or liabilities of the
Acquired Entity)? What impact do such liabilities have on the FMV? Has
this determination changed since the late 1970s/early 1980s? If it has
changed, how has it changed?
6. Should the Commission require the Acquiring Person to provide
the basis for its FMV determination? If so, why? If not, why not?
II. Real Estate Investment Trusts (Section 7A(c)(1) of the Clayton Act)
Congress created real estate investment trusts (``REITs'') in 1960
to allow for the pooling of funds from many small investors to invest
in real estate, and gave REITs preferential tax treatment. The
legislative history indicates that REIT status was meant to be limited
to ``clearly passive income from real estate investments, as contrasted
to income from the active operation of businesses involving real
estate,'' and those real estate trusts engaging in active business
operations would not be afforded REIT tax status.\3\
---------------------------------------------------------------------------
\3\ H.R. Rep. No. 86-2020, pt. 2, at 3-4 (1960).
---------------------------------------------------------------------------
As a result, the PNO has long taken the informal staff position
that when a REIT acquires real property (and assets incidental to the
real property), the acquisition is exempt from HSR reporting under
section 7A(c)(1) of the Clayton Act, the statutory ordinary course of
business exemption. This position is based on the presumption that
REITs are solely buying, owning, leasing, and selling real property,
and therefore any acquisition of real property is exempt because it is
done in the ordinary course of the REIT's business and is unlikely to
violate the antitrust laws.
The Commission is aware that the Internal Revenue Service (``IRS'')
subsequently made changes in tax law to remove restrictions on REITs
and expand the beneficial tax treatment. As a result, many REITs are no
longer solely buying, owning, leasing, and selling real property.\4\ In
fact, many REITs are now engaged in the active operation of businesses.
For instance, REITs operate assisted living and other healthcare
businesses, as well as companies that own cell towers and billboards,
located on REIT-owned real property. Due to these changes, the
Commission believes it is possible that a REIT's acquisition of real
property may no longer be suitable for the blanket exemption offered
under section 7A(c)(1) of the Act. The Commission would like to
understand in more detail the current structure and operation of REITs
through responses to the following questions:
---------------------------------------------------------------------------
\4\ Proposed Rulemaking, 79 FR 27508 (May 14, 2014); Correction
to Proposed Rulemaking, 79 FR 38809 (July 9, 2014); Final
Regulations, 81 FR 59849 (Aug. 31, 2016).
---------------------------------------------------------------------------
1. Have REITs evolved from entities that own only real property to
entities that can hold operating companies?
a. If so, what has led to the evolution of REITs becoming entities
that can hold operating companies?
b. How have changes in tax laws or regulations influenced this
evolution?
2. How does an operating company convert to a REIT?
a. Do REIT structures involve one Ultimate Parent Entity (``UPE'')?
Two UPEs? How often is each type used? Why?
b. If a REIT has more than one UPE, what is the relationship
between those UPEs?
c. If a REIT has more than one UPE, is there an entity above the
UPEs that makes decisions for both of them?
3. Is there a way to distinguish REITs that own only real property
from those that hold operating companies? If yes, what are the ways to
distinguish REITs that own only real property and those that hold
operating companies? For instance, are there differences in how they
are structured? How else are they different?
4. Assume the PNO's informal staff position exempting REITs did not
exist and REITs had to rely solely on the real property exemptions,
Sec. Sec. 802.2 and 802.5.
a. Are there situations in which REIT transactions would no longer
be exempt? If so, what kinds of situations?
b. How often would the Sec. Sec. 802.2 and 802.5 exemptions come
into play?
c. Would it be easy for REITs to apply Sec. Sec. 802.2 and 802.5
to transactions? If so, why? If not, why not?
III. Non Corporate Entities (16 CFR 801.1f(1)(ii))
The Act applies to acquisitions of voting securities or assets. The
rise of non-corporate entities, such as partnerships and limited
liability companies, has presented challenges under the Act because the
PNO had long taken the position that interests in unincorporated
entities were neither voting securities nor assets. Thus, any
acquisition of interests in such entities had not been a reportable
event unless 100% of the interests was acquired, in which case the
acquisition was deemed to be that of all of the underlying assets of
the partnership or other unincorporated entity.'' \5\
---------------------------------------------------------------------------
\5\ 69 FR 18686, 18687 (Apr. 8, 2004).
---------------------------------------------------------------------------
At first, this approach did not present significant issues, because
non-corporate entities were created as acquisition vehicles and used to
effectuate transactions, not to separately hold operating
businesses.\6\ But the role of non-corporate entities evolved. As the
Commission noted in its 2004 Notice of Proposed Rulemaking, ``[t]he use
of unincorporated entities is expanding, and such entities are
increasingly engaging in acquiring interests in other corporate and
unincorporated entities. For example, the number of corporate income
tax filings increased from 4,630,000 to 5,711,000 (23%) between 1994
and 2002, while the number of partnership returns, including LLCs taxed
as partnerships, increased from 1,550,000 to 2,236,000 (44%) during the
same period. In addition, a number of states have amended their
statutes in recent years to allow limited liability companies to merge
with other types of legal entities.'' \7\ As a result, the Commission
determined in its 2005 Final Rule that the acquisition of control, 50%
or more of the non-corporate interests (``NCIs'') in a non-corporate
entity (``NCE''), would henceforth be reportable.\8\
---------------------------------------------------------------------------
\6\ Formal Interpretation 15, 63 FR 54713 (Oct. 13, 1998)
(amended 1999) (amended 2001).
\7\ 69 FR at 18688.
\8\ 70 FR 11502, 11504 (Mar. 8, 2005).
---------------------------------------------------------------------------
The Commission is aware that NCEs have continued to evolve. For
instance, acquisitions of NCIs are often captured in Securities
Purchase Agreements, which imply that NCIs are now deemed to be more
like voting securities. Thus, the Commission believes that it is
appropriate to re-evaluate the nature of NCEs and NCIs to determine
whether NCEs are the equivalent of corporate entities and NCIs function
more as voting securities. To that end, the Commission would like to
understand in more detail the evolution of NCEs and NCIs since its 2005
Final Rule,\9\ through responses to the following questions:
---------------------------------------------------------------------------
\9\ 70 FR 11502 (Mar. 8, 2005).
---------------------------------------------------------------------------
1. Have NCEs evolved in form and substance since 2005? If they have
evolved, what significant changes have occurred to shape the evolution
of NCEs between 2005 and now?
a. Have the distinctions between NCEs and corporate entities
evolved since 2005? If they have evolved, what significant changes have
occurred to make NCEs and corporate entities more or less distinct
between 2005 and now?
[[Page 77047]]
b. Have the distinctions between NCIs and voting securities evolved
since 2005? If they have evolved, what significant changes have
occurred to make NCIs and voting securities more or less distinct
between 2005 and now?
c. Are NCIs currently the same as voting securities? If so, how? If
not, how are they different? Is this different from 2005? If so, how?
What has changed between 2005 and now?
d. Does any category of NCIs currently carry a right equivalent to
the right to vote for the election of the board of directors of a
corporate entity? Is this different from 2005? If so, how? What has
changed between 2005 and now?
e. Should the reporting obligations for the acquisition of an
interest in a corporate entity and non-corporate entity differ? Is this
different from 2005? If so, how? What has changed between 2005 and now?
2. Have the benefits and drawbacks of becoming an NCE evolved since
2005? If they have evolved, have the incentives to become an NCE
changed since 2005? If so, how? If not, why not? What has changed
between 2005 and now?
IV. Acquisitions of Small Amounts of Voting Securities (16 CFR 801.1,
802.9, 802.64)
Since the implementation of the HSR program, there has been a
significant expansion of the holdings of investment entities, including
investment funds and institutional investors, as well as expanded
interest and ability of such shareholders to participate in corporate
governance.\10\ In addition, changes in investment behavior have
resulted in some investment entities holding small stakes in a large
number of firms, including competitors. This has caused some to raise
concerns about the competitive effects of common ownership--that is,
the competitive effect of an investor holding small minority positions
in issuers that operate competing lines of business.\11\
---------------------------------------------------------------------------
\10\ See, e.g., Edward Rock, Adapting to the New Shareholder-
Centric Reality, 161 U. Pa. L. Rev. 1907 (2013).
\11\ Matthew Backus, Christopher Conlon, & Michael Sinkinson,
Common Ownership in America: 1980-2017, forthcoming, American
Economic Journal (forthcoming 2020) https://chrisconlon.github.io/site/common_owner.pdf. (These concerns (and their validity) were
discussed at the Federal Trade Commission's Hearings on Competition
and Consumer Protection in the 21st Century, Hearings on Common
Ownership (Dec. 6, 2018). The transcript of that session is
available on the FTC's website, here: https://www.ftc.gov/system/files/documents/public_events/1422929/ftc_hearings_session_8_transcript_12-6-18_0.pdf, and the slide
presentations of the participants are available here, https://www.ftc.gov/system/files/documents/public_events/1422929/cpc-hearings-nyu_12-6-18.pdf.).
---------------------------------------------------------------------------
In light of these developments, the Commission is using this ANPRM
to take a fresh look at the rules that apply to acquisitions of voting
securities by investment entities to determine whether updates may be
necessary. The Commission seeks information on the following rules:
A. Definition of ``Solely for the Purpose of Investment'' (16 CFR
801.1, 802.9)
Section (c)(9) of the HSR Act exempts from the requirements of the
Act ``acquisitions, solely for the purpose of investment, of voting
securities, if, as a result of such acquisition, the securities
acquired or held do not exceed 10 per centum of the outstanding voting
securities of the issuer.'' To implement this statutory limitation, 16
CFR 802.9 exempts from the requirements of the Act an acquisition of
voting securities if made solely for the purpose of investment and if,
as a result of the acquisition, the Acquiring Person would hold 10% or
less of the outstanding voting securities of the issuer, regardless of
the dollar value of the voting securities so acquired or held. Under 16
CFR 801.1(i)(1), ``[v]oting securities are held or acquired `solely for
the purpose of investment' if the person holding or acquiring such
voting securities has no intention of participating in the formulation,
determination, or direction of the basic business decisions of the
issuer.'' \12\
---------------------------------------------------------------------------
\12\ 16 CFR 801.1(i)(1).
---------------------------------------------------------------------------
In light of changing investor engagement with issuers, the
Commission is interested in knowing if it is appropriate to rethink the
definition of ``solely for the purpose of investment'' in 16 CFR
801.1(i)(1) and the exemption in 16 CFR 802.9. To that end, the
Commission seeks to understand the incentives involved in applying the
exemption in 16 CFR 802.9 through responses to the following questions:
1. The ability to rely on 16 CFR 802.9 depends on whether a
potential filing person ``has no intention of participating in the
formulation, determination, or direction of basic business decisions of
the issuer.'' \13\
---------------------------------------------------------------------------
\13\ 16 CFR 801.1(i)(1).
---------------------------------------------------------------------------
a. Are there benefits to this approach? If so, what are the
benefits?
b. Are there drawbacks to this approach? If so, what are the
drawbacks?
c. How could this approach be changed? How would such a change
impact investors and issuers?
d. What are the ``basic business decisions'' of the issuer?
i. Is it clear what decisions comprise the ``basic business
decisions'' of the issuer?
ii. Are there activities that clearly do not relate to the basic
business decisions?
iii. Are there activities that clearly do relate to the basic
business decisions?
iv. Is there uncertainty about whether an activity relates to the
basic business decisions? If so, why is there uncertainty? To what
extent is there uncertainty about whether an activity relates to the
basic business decisions?
e. Should the Commission define the ``basic business decisions of
the issuer'' as used in the existing Rule?
i. What should the definition include?
ii. Should specific items be excluded from the definition? Which
items?
iii. What are the benefits of providing a definition?
iv. What are the risks of providing a definition?
f. Is it clear what is meant by ``no intention of participating''
in the formulation, determination, or direction of the basic business
decisions?
i. What type of activity related to determining whether to
participate in business decisions currently takes one out of the
exemption, or at what point in the process of deciding whether to
participate in business decisions is one no longer within the
exemption?
ii. What type of activity related to determining whether to
participate in business decisions should result in the exemption no
longer applying, or at what point in the process of deciding whether to
participate in business decisions should one no longer be within the
exemption?
iii. Should the language be changed to allow reliance on the
exemption until the Acquiring Person has made an affirmative decision
to participate in the basic business decisions? If so, what would
constitute an affirmative decision to participate in the basic business
decisions?
2. In general, for HSR purposes, what differentiates the activities
of investors who invest solely for the purpose of investment and
investors who do not invest solely for the purpose of investment? Have
these activities changed since 1978? If so, how?
a. In what activities do investors who invest solely for the
purpose of investment engage? Have these activities changed since 1978?
If so, how?
b. What categories of interaction with management indicate an
investor's intention is not to hold voting securities solely for the
purpose of investment? For example, would those categories include
things like discussions of governance issues, discussions of
[[Page 77048]]
executive compensation, or casting proxy votes? Have these categories
changed since 1978? If so, how?
c. Does the market capitalization of the issuer affect the
determination of whether an investment is solely for the purpose of
investment or not solely for the purpose of investment? Has this
changed since 1978? If so, how?
3. How does the Commission's interpretation of ``solely for the
purpose of investment'' compare to the Securities and Exchange
Commission's (``SEC'') approach to ``passive'' investors? \14\
---------------------------------------------------------------------------
\14\ Under SEC Rule 13d-1(c), certain beneficial owners may file
a short form statement on Schedule 13G in lieu of a 13D statement if
that person ``has not acquired the securities with any purpose, or
with the effect, of changing or influencing the control of the
issuer, or in connection with or as a participant in any transaction
having that purpose or effect, including any transaction subject to
17 CFR 240.13d-3(b), other than activities solely in connection with
a nomination under 17 CFR 240.14a-11.'' 17 CFR 240.13d-1(c). The SEC
relies on a ``control purpose'' test to identify ``passive''
investments; that is, beneficial owners that acquired shares ``not
with the purpose nor with the effect of changing or influencing the
control of the issuer.'' The SEC has a broad view of the types of
activities that could show such a ``control purpose,'' and that
determination is assessed based on a totality of the circumstances.
For instance, a shareholder that fails to qualify as an investor
solely for the purpose of investment under the HSR Act may
nonetheless be eligible to use Schedule 13G depending on various
factors, such as the subject matter of the shareholder's discussions
with the issuer's management. See Exchange Act Sections 13(d) and
13(g) and Regulation 13D-G Beneficial Ownership Reporting,
Compliance and Disclosure Interpretations (``C&DIs''), Question
103.11 (July 14, 2016) https://www.sec.gov/divisions/corpfin/guidance/reg13d-interp.htm#103.11.
---------------------------------------------------------------------------
a. Assuming no change in the SEC approach, could the Commission
adopt the SEC approach? If yes, why? If no, why not?
b. What would be the benefits of adopting the SEC approach? Why?
c. What would be the drawbacks of adopting the SEC approach? Why?
d. Does the different role of each agency justify different
approaches for investors who hold positions solely for the purpose of
investment? If yes, why? If no, why not?
4. How does the Commission's interpretation of ``solely for the
purpose of investment'' compare to the elements that must be disclosed
in Item 4 of Schedule 13D filed with the SEC? \15\
---------------------------------------------------------------------------
\15\ Item 4 of Schedule 13D requires filers to state the purpose
or purposes of the acquisition of securities of the issuer and to
describe any plans or proposals which they might have. 17 CFR
240.13d-10117 CFR 240.13d-101.
---------------------------------------------------------------------------
a. Assuming no change to the SEC rule, could the Commission adopt
the SEC elements? If yes, why? If no, why not?
b. What would be the benefits of adopting the SEC elements?
c. What would be the drawbacks of adopting the SEC elements?
d. Does the different role of each agency justify different
approaches for investors who hold positions solely for the purpose of
investment?
5. How do the activities of investment firms differ from those of
operating companies?
a. Should the Commission treat different types of acquirers
differently for the purpose of the exemption? If yes, why? If no, why
not?
b. Should the Commission treat different types of investment
companies differently for the purpose of the exemption (for example,
mutual fund companies versus hedge fund companies)? If yes, why? If no,
why not?
6. Should the Commission preclude parties from using the exemption
only if they have taken certain specified actions? If yes, why? If no,
why not?
a. What actions should disqualify an Acquiring Person from being
able to use the exemption?
i. Should the actions be limited to actions that facilitate or
encourage coordination among competitors?
ii. Should actions that affect competition, even if aimed only at a
single competitor, preclude the use of the exemption? If yes, why? If
no, why not?
iii. Should actions that change the incentives to compete, even if
aimed only at a single competitor, preclude the use of the exemption?
If yes, why? If no, why not?
iv. What other actions should preclude utilizing the exemption?
b. Would allowing the Acquiring Person to acquire 9.9% of the
voting securities of the Issuer prior to taking the specified action
undercut the ability to obtain filings early enough to ascertain
potential competitive harm before a transaction is consummated? If yes,
why? If no, why not?
c. Would such a conditioning of the loss of the exemption be
consistent with the wording of the statute, including ``solely'' and
the ``purpose'' of the acquisition? If yes, why? If no, why not?
i. Is the acquisition solely for investment if the Acquiring Person
is considering taking action inconsistent with the exemption, but has
not yet taken the action?
ii. Is the acquisition for the purpose of investment if the
Acquiring Person has determined to take action inconsistent with the
exemption, but has not yet taken the action?
d. Should the Commission require an HSR filing for past
acquisitions once the specified actions have been taken? If yes, why?
If no, why not?
i. Would this be consistent with the HSR Act's requirement to make
the filing prior to the acquisition? If yes, why? If no, why not?
ii. Would this be consistent with the requirement that the
Acquiring Person certify that it has a good faith intent to make an
acquisition requiring notification? If yes, why? If no, why not?
B. Definition of Institutional Investors (16 CFR 802.64)
Under Sec. 802.64, institutional investors are exempt from HSR
reporting when making acquisitions of 15% or less of voting securities
in the ordinary course of business and solely for purpose of
investment. During the initial HSR rulemaking in 1978, entities were
identified as institutional investors because they were viewed as
constrained by law (e.g., non-profits) or fiduciary duty (e.g., pension
trusts, insurance companies, etc.), or generally uninterested in
``affecting management of the companies whose stock they buy'' (e.g.,
broker-dealers).\16\ The list identifying what type of entity is
considered an institutional investor has never been updated.
---------------------------------------------------------------------------
\16\ 43 FR 33450, 33503 (July 31, 1978).
---------------------------------------------------------------------------
It is unclear to the Commission whether this exemption should be
maintained and implemented in the same manner in which it was first
promulgated in 1978. In light of changes in the investor landscape
since that time, the Commission may need to update the list of
institutional investors that are presumed to engage in acquisitions
solely for the purpose of investment. Thus, the Commission aims to
understand the current institutional investor landscape in order to
make that determination through responses to the following questions:
1. Given that 16 CFR 802.64 has not changed since 1978, does it
need to be updated?
a. Does 16 CFR 802.64 accurately reflect the universe of entities
that make investments in the ordinary course of business solely for the
purpose of investment? Are there entities currently listed in the
exemption that should be removed? If so, why?
b. Are there entities not currently listed that should be treated
as institutional investors? If so, why and what are they? Explain the
justification for treating the entity as an institutional investor:
Does it fit within the paradigm identified by the Commission in first
promulgating 16 CFR 802.64 (i.e., (i) constrained by law; (ii)
constrained by fiduciary duty; or (iii) uninterested in affecting
management of the companies whose stock they buy)? Are there other
reasons the entity should be treated as an institutional investor?
[[Page 77049]]
c. Should the Commission provide a list of indicia that an investor
must meet to qualify as an institutional investor for purposes of the
HSR Act, instead of a list of entities considered to be institutional
investors? If yes, why and what should these indicia be? If no, why
not?
d. Is the 15% level for the Commission's exemption still consistent
with the purpose of the HSR Act? What evidence is there that the level
should be higher or lower?
The SEC has also promulgated a definition of ``institutional
investors'' as part of its beneficial ownership disclosure
requirements. When a person or group of persons acquires beneficial
ownership of more than five percent of a voting class of a company's
equity securities registered under the Securities Exchange Act, they
are required to file a Schedule 13D with the SEC.\17\ Depending upon
the facts and circumstances, the person or group of persons may be
eligible to file the more abbreviated Schedule 13G in lieu of Schedule
13D.\18\ One of the exemptions relates to acquisitions of securities in
the ordinary course of business by a ``qualified institutional
investor'' under Rule 13d-1(b).\19\
---------------------------------------------------------------------------
\17\ Securities Exchange Act of 1934, 15 U.S.C. 78a et seq., and
17 CFR 240.13d-101.
\18\ Section 13(g) was added to the Exchange Act as part of the
Domestic and Foreign Investment Improvement Disclosure Act of 1977.
Public Law 95-214, sec. 203, 91. Stat. 1494.
\19\ Under SEC Rule 13d-1(b)(1)(i)-(ii)(A)-(K), certain
beneficial owners may file a short form statement on Schedule 13G in
lieu of a 13D statement under certain conditions.
---------------------------------------------------------------------------
2. How does the Commission's definition of institutional investor
compare to the definition used by the SEC in identifying a person able
to file a Schedule 13G?
a. Assuming no change in the SEC rule, should the Commission adopt
the SEC definition of a person who acquires voting securities in the
ordinary course of business and not with the purpose nor with the
effect of changing or influencing the control of the issuer? If yes,
why? If no, why not?
b. What would be the benefits of adopting the SEC definition?
c. What would be the drawbacks of adopting the SEC definition?
d. Does the different role of each agency justify different
definitions for institutional investors?
3. What are the activities of institutional investors and how have
they changed since 1978?
a. What activities do institutional investors engage in with the
issuers whose shares they hold? Have these activities changed since
1978? If so, how have these activities changed?
i. What is the scope of ``shareholder engagement'' that
institutional investors undertake? Has this changed since 1978? If so,
how has it changed?
ii. What topics or issues are the subject of such engagement? Have
these topics or issues changed since 1978? If so, how have they
changed?
iii. How often does such engagement occur? Has this changed since
1978? If so, how has this changed?
iv. Does the amount, degree, or type of issue discussed vary by
issuer, or are there consistent themes of discussion and engagement?
Has this changed since 1978? If so, how has this changed?
v. When do institutional investors participate in the formulation,
determination, or direction of the basic business decisions of issuers?
Has this changed since 1978? If so, how has it changed?
b. How do index funds fit within the portfolios of institutional
investors? Have index funds evolved since 1978? If so, how have they
evolved?
i. Why do intuitional investors choose to create an index fund,
exchange-traded fund, or the like? What are the benefits and drawbacks
of creating such a fund?
ii. How does the acquisition of voting securities held by an index
fund, exchange-traded fund, or the like occur? Do acquirors use an
algorithm or some other automated mechanism to facilitate acquisitions?
iii. Who oversees an index fund, exchange-traded fund, or the like?
Is there one person or entity within an investment organization tasked
with overseeing such a fund? More than one? How often is it one versus
more than one?
4. How do institutional investors manage holdings in the same
issuer? How has this changed since 1978?
a. Do institutional investors jointly manage holdings in the same
issuer? Do they separately manage holdings in the same issuer? Both?
Has this changed since 1978? If so, how has it changed?
b. How do institutional investors make the decision to jointly or
separately manage holdings in the same issuer? Has this changed since
1978? If so, how has this changed?
c. Do answers to any of the above questions depend on the type of
issuer or the type of institutional investor or other factors? If so,
what factors are relevant? How does each factor influence the actions
of institutional investors? Have the factors changed since 1978? If so,
how have they changed?
5. How do institutional investors apply the concept of solely for
the purpose of investment? Has this changed since 1978? If so, how has
it changed?
a. Do the entities listed in 16 CFR 802.64 currently hold the
voting securities of issuers solely for the purpose of investment? How
does this differ from institutional investor behavior in 1978? What
significant changes in institutional investor behavior have occurred
between 1978 and 2020?
b. What kinds of entities not listed in 16 CFR 802.64 currently
hold the voting securities of issuers solely for the purpose of
investment? How does the current behavior of these entities differ from
their behavior in 1978?
c. If institutional investors make certain acquisitions solely for
the purpose of investment and other acquisitions not solely for the
purpose of investment, is it appropriate to provide a status exemption
for all of their activities? If yes, why? If no, why not?
d. Do institutional investors rely on 16 CFR 802.64 to exempt
acquisitions in or by index funds, exchange-traded funds or the like?
If so, how?
V. Influence Outside the Scope of Voting Securities (16 CFR 801.1,
802.31)
The HSR Act applies to the acquisition of assets and voting
securities. ``The term voting securities means any securities which at
present or upon conversion entitle the owner or holder thereof to vote
for the election of directors of the issuer, or of an entity included
within the same person as the issuer.'' \20\ The acquisition of a
voting security carries with it the right to influence the business of
a company through the ability to vote for the directors of that
company, among other things.
---------------------------------------------------------------------------
\20\ 16 CFR 801.1(f)(1)(i).
---------------------------------------------------------------------------
The Commission is aware, however, that there are ways to gain
influence over a company without the acquisition of the right to vote
for the election of directors inherent in voting securities. For
instance, the acquisition of convertible voting securities or the use
of board observers could each result in the ability to influence a
company's business decisions. Currently, neither the acquisition of
convertible voting securities nor rights to be a board observer are
reportable events under the Act. The Commission, therefore, needs to
ascertain whether the acquisition and exercise of these rights provide
opportunities to influence an issuer's business decisions, and thus
should be reportable events.
[[Page 77050]]
A. Convertible Voting Securities (16 CFR 802.31)
The acquisition of convertible debentures (convertible into common
stock), options, warrants, or preferred shares, even with no present
right to vote for directors, may result in the ability to influence the
business of a company. The Rules capture these kinds of stakes in the
concept of a convertible voting security. ``The term convertible voting
security means a voting security which presently does not entitle its
owner or holder to vote for directors of any entity.'' \21\ Section
802.31 exempts the acquisition of convertible voting securities.
---------------------------------------------------------------------------
\21\ 16 CFR 801.1(f)(2).
---------------------------------------------------------------------------
The PNO has taken the informal position that the acquisition of
convertible voting securities, when accompanied by the right to
designate or appoint individuals to the board of directors of the
issuer equal to the percentage of voting securities that would be held
upon conversion, is reportable under the Act. The Commission is
considering revising Sec. 802.31 to explicitly require compliance with
the HSR Act's reporting requirements when the acquisition of
convertible voting securities is coincident with the Acquiring Person
having or obtaining the right to designate or appoint any individuals
to the board of the issuer. The Commission aims to understand the
potential benefits and burdens of such a change through responses to
the following questions:
1. Is the acquisition of convertible voting securities, when
accompanied with the right of appointment or designation of individuals
to the issuer's board of directors, equivalent to the acquisition of
voting securities with the present right to vote for election of the
issuer's board of directors? In what ways are they the same and in what
ways are they different? What provisions could accompany the right to
appoint that would make the acquisition the most like an acquisition of
voting securities? What provisions make them different for competition
purposes? Have these provisions changed since 1978? If so, how have
they changed?
2. Why would an Acquiring Person choose one alternative over the
other? Have the benefits of one alternative over another changed since
1978?
a. Is there a benefit of acquiring convertible voting securities
while holding or obtaining the right to appoint or designate
individuals to an issuer's board of directors, as compared to the
acquisition of securities that have the present right to vote? If so,
what is the benefit? Has the benefit changed since 1978? If so, how has
it changed?
b. Under what situations does such a benefit arise? Have these
situations changed since 1978? If so, how have they changed?
3. What are the reasons the Commission should or should not require
a filing whenever the acquirer of convertible non-voting securities
receives a right to designate one or more directors prior to
conversion?
a. Should issuers that have cumulative voting be subject to the
same requirements as issuers that do not have cumulative voting? Why
should they be subject to different requirements? Is there a difference
in how much influence an acquirer would have based on whether the
issuer has cumulative voting? Why? How would the Commission be able to
distinguish when it is a problem and when it is not?
4. What would be the burden associated with this possible change?
a. Would the burden fall most on an identifiable class of
transactions? How would such a change affect how an identifiable class
of transactions is structured?
b. Would such a change introduce significant inefficiencies into
the market for corporate control? What would be the effect of that
change in the market?
B. Board Observers
Another potential way to gain influence over a company, beyond the
scope of acquiring voting securities, is through board observers. The
Commission understands that it is becoming increasingly common for
issuers and NCEs to include board observers as part of their governance
structure. Issuers and NCEs often grant rights to select and appoint
board observers to investors with significant equity, in addition to or
in lieu of providing investors with board seats. Even though board
observers lack the ability to vote on matters that come before the
issuer's board, they may nevertheless have significant influence over
the outcome of matters submitted to the board for approval.\22\ At the
very least, board observers gain insight into an issuer's strategic
decision-making, which is not only useful to the investor sponsoring
the board observer, but may also be useful to competitors in the
market, especially when those board observers also serve as officers or
directors of a competitor.\23\ Companies likely benefit from
interacting with board observers because company management can obtain
additional investor insight without having to alter the composition or
voting balance on the board.
---------------------------------------------------------------------------
\22\ Obasi Investment Ltd. et al. v. Tibet Pharmaceuticals, Inc.
et al., 931 F.3d 179, 183 (3d Cir. 2019).
\23\ See Complaint, In re Altria Group/JUUL Labs, Dkt. 9383, ]
9, at https://www.ftc.gov/system/files/documents/cases/d09393_administrative_part_iii_complaint-public_version.pdf.
---------------------------------------------------------------------------
Given the opportunities that board observers have to interact with
corporate officers, directors, and other managers, and to gain access
to confidential information related to strategic and operational
decisions, the Commission would like to better understand the role of
board observers. In particular, the Commission would like to know how
investors might use board observers' rights to influence competitive
decision-making of issuers and NCEs to ascertain whether the
acquisition of rights that provide opportunities to wield this kind of
influence should be reportable under the Act. To that end, the
Commission seeks responses to the following questions:
1. What types of information are available to an issuer/NCE board
observer?
a. With what frequency is a board observer invited to all meetings?
Is a board observer always entitled to all info provided to board
members? Is a board observer permitted to request additional
information beyond what is presented at a board meeting? If so, with
what frequency?
b. Are board observers subject to any restrictions on how they can
use the information they obtain in their capacity as board observers?
Are these restrictions based on contract, bylaws or regulations?
c. Do issuers/NCEs create formal review processes for information
scheduled to be sent to a board observer? If so, with what frequency?
Are outside counsel involved in monitoring compliance? If so, with what
frequency?
d. Is the information scheduled to be sent to a board observer
subject to a non-disclosure agreement that limits its dissemination to
others, including officers and directors of competitors or investors in
competitors?
e. Do issuers/NCEs draft formal guidance for their boards as to
what topics should not be discussed in the presence of board observers?
If so, with what frequency? Are outside counsel involved in monitoring
compliance? If so, with what frequency?
2. What means does an issuer/NCE board observer have to influence
board policies or the strategic or operational direction of the firm?
[[Page 77051]]
a. Does a board observer ever enjoy any special right of notice or
consultation regarding major capital expenditures or strategic
decisions?
b. Does a board observer have access, outside of board meetings, to
managers in the corporation, to investment committee members in an NCE,
or to persons with similar decision-making roles regarding the
operations of the business? If so, with what frequency?
c. Do board observers have the ability to request a meeting of the
issuer's/NCE's board? If so, with what frequency?
d. Do issuers/NCEs impose restrictions on a board observer's
speaking role during board meetings? If so, with what frequency? How
common are ``silent'' board observers?
e. How frequently do board observers move into senior executive
roles at issuers/NCEs?
3. What are the parameters of the board observer role?
a. Is a board observer's relationship with the issuer/NCE always
explicitly defined in a written agreement between the issuer and the
investor? How common are informal board observer arrangements?
b. Are board observers (or those who sponsor their observation of
board matters) covered by conflict of interest rules or black-out
periods such as those that limit investments by board members?
4. Are there any protocols on selection/approval of board observers
and/or processes in place to ensure that observers are not in a
position to facilitate sharing of competitively sensitive information
among competitors?
5. For all of the questions above, do rules or practices regarding
board observer rights to obtain confidential information differ
substantially between issuers and NCEs? What factors account for any
such differences?
VI. Transactions or Devices for Avoidance (16 CFR 801.90)
16 CFR 801.90 provides that the Commission must disregard the
structure of transactions or devices used by the parties for the
purpose of avoiding the HSR Act requirements and review the substance
of the transaction as a whole to determine whether an HSR filing is
required. The PNO often receives questions about whether specific
scenarios would be violations under Sec. 801.90, and the PNO has
occasionally offered informal staff positions on Sec. 801.90. For
instance, the PNO has an informal staff position that says if a target
makes a payout prior to its acquisition in the form of an extraordinary
dividend, such a payment would not trigger 16 CFR 801.90 if, as a
result of the dividend, the target no longer meets the size of person
test.\24\ The PNO's informal staff position is based on the idea that
if an extraordinary dividend reduces the target's cash on hand, it is
unlikely to present a 16 CFR 801.90 issue.
---------------------------------------------------------------------------
\24\ Am. Bar Ass'n., Premerger Notification Practice Manual,
Interpretation 96 (5th ed.).
---------------------------------------------------------------------------
But there are situations where the purpose of such a payout may be
more complicated. For instance, if the payout involves more than the
distribution of cash on hand, this could present an issue under 16 CFR
801.90. Each issuance of an extraordinary dividend or like payment must
be carefully analyzed to make sure that it is not a device for
avoidance under Sec. 801.90. The Commission has questions about
whether filing parties are engaging in this analysis or, instead,
assuming that every extraordinary dividend is not a device for
avoidance under Sec. 801.90. In order to determine which are and are
not devices for avoidance, the Commission would therefore like to
understand the mechanisms by which targets engage in these and other
kinds of practices through responses to the following questions:
1. What mechanisms do targets use to pay out extraordinary
dividends and what are the reasons for such dividends?
a. Is the focus on the reduction of cash on hand or are there other
motivations for issuing such dividends? If so, what are the other
motivations?
b. Are there other ways of structuring extraordinary dividends? If
so, what are they? If not, why not?
c. How often do targets issue extraordinary dividends in advance of
being acquired? What are the reasons that targets issue such dividends?
d. Is the buyer ever involved in the target's decision to issue an
extraordinary dividend in advance of an acquisition? Why or why not?
2. Do targets use mechanisms other than extraordinary dividends to
reduce cash on hand?
a. If so, what are they and how are they structured? If not, why
not?
b. Is the buyer involved? If yes, why and with what frequency? If
not, why not?
3. What other actions should the Commission scrutinize as possible
devices for avoidance?
VII. Filing Issues (16 CFR 802.21, 16 CFR Part 803 Appendix A and B)
The Commission has a strong interest in an HSR filing process and
an HSR Form that garners competitively significant information to
assist the Agencies in their review of transactions. To that end, the
Commission intends to explore amending (a) the 16 CFR 802.21 five-year
period during which a party may acquire additional voting securities
without refiling, and (b) the requirement in Item 8 of the HSR Form to
disclose certain prior acquisitions.
A. Acquisitions of Voting Securities That Do Not Cross the Next
Threshold (16 CFR 802.21)
Under 16 CFR 802.21, filing parties have five years from the end of
the waiting period to acquire additional voting securities without
making another filing, as long as the additional acquisitions do not
exceed the next threshold. For instance, Party A files to cross the
$100 million threshold (as adjusted) on January 1 and receives early
termination on January 20, which ends the waiting period. Party A then
has five years from January 20 to continue to acquire voting securities
of the same issuer up to the next threshold, in this case $500 million
(as adjusted), as long as it crosses the $100 million threshold (as
adjusted) within one year.
The time period in proposed Sec. 802.21 was 180 days, but numerous
comments persuaded the Commission this time period was too short.\25\
In the final rules, the Commission chose a period of five years, both
as a result of these comments and because it made sense to correlate
the timing of the exemption with the timing of the Census and resulting
updated data.\26\ Given the changes in worldwide economic activity
since 1978, Commission is now concerned that the Sec. 802.21 five-year
period may be too long. At the time of the initial filing, the
transaction may not present competition concerns, but such concerns
could develop as a result of changes in the lines of business of the
Acquiring Person and Acquired Person during the five-year period, but
those changes would not require a new filing. As a result, the
Commission seeks to understand the impact of shortening the Sec.
802.21 five-year period through responses to the following questions:
---------------------------------------------------------------------------
\25\ 43 FR 33450, 33493 (July 31, 1978).
\26\ Id.
---------------------------------------------------------------------------
1. Have there been changes in economic activity significant enough
to raise concerns that the Commission may miss important competitive
effects if it does not shorten the five-year term?
2. If there are reasons to believe that the Sec. 802.21 five-year
period is too long, what period would address concerns that additional
acquisitions of the Acquired Entity present competitive
[[Page 77052]]
concerns because the lines of business of the Acquiring Person and/or
Acquired Person have changed? Why would another period be more
appropriate?
3. Is there is a class of Acquiring Persons for whom the decrease
in the exemption period would cause significant burden? If not, why
not? If so, how?
B. Prior Acquisitions
When the Acquiring Person and the Acquired Person report in the
same or ``overlapping'' NAICS revenue code in Item 5 of the HSR Form,
the Acquiring Person must report certain prior acquisitions in Item 8:
(1) The acquisition of 50% or more of the voting securities of an
issuer or 50% or more of non-corporate interests of an unincorporated
entity (subject to $10 million limitation) and (2) any acquisition of
assets valued at or above the statutory size-of-transaction test at the
time of their acquisition. Item 8 limits the Acquiring Person's
disclosure to those acquisitions within the overlapping NAICS code over
the last five years.
The Commission is concerned that Item 8 does not capture all
competitively significant acquisitions. There are several reasons why
this might be the case. For instance, the Acquiring Person does not
have to disclose prior acquisitions when it and the Acquired Person
report revenue in different NAICS codes. Nevertheless, overlapping
NAICS codes are imperfect predictors of whether the acquisition
presents competitive concerns that need review. For instance, an
Acquiring Person is not subject to the disclosure requirement if a
prior acquisition involved a potential competitor with no revenue in an
overlapping NAICS code at the time of the acquisition. Similarly, an
Acquiring Person need not disclose a prior acquisition that involved a
vertical relationship when companies at different levels of the
distribution chain report in different NAICS codes. As a result, the
Commission is considering eliminating the overlapping NAICS code
limitation in Item 8 so that the Acquiring Person would have to list
all its acquisitions of 50% or more of the voting securities of an
issuer or 50% or more of non-corporate interests of an unincorporated
entity (subject to the $10 million limitation) and any acquisition of
assets valued at or above the statutory size-of-transaction test at the
time of their acquisition in the five years prior to filing. The
Commission seeks comment on this potential change through responses to
the following questions:
1. What would be the benefit or burden associated with this
possible change? Are there any classes of transactions for which the
benefit or burden would be greater? If there are classes of
transactions for which the benefit is greater, why is the benefit
greater? If there are classes of transactions for which the burden is
greater, why is the burden greater?
2. Is there any way to distinguish prior acquisitions that might
have competitive significance from those that do not, such that the
Commission would not need to require a list of all prior acquisitions?
In addition to the topics outlined above, commenters are welcome to
provide input on any other HSR Rule. As part of that input, identify
the changes in investor behavior or competitive dynamics that would
justify a change in the Commission's current approach.
By direction of the Commission.
April Tabor,
Acting Secretary.
Statement of Commissioner Rohit Chopra
September 21, 2020.
Summary
Premerger notification is a critical data source, but
the Commission faces enormous information gaps when seeking to
detect and halt anticompetitive transactions.
While the proposed rule closes a loophole when it comes
to investment manager holdings, the proposed approach to exempt a
wide swath of minority stakes is concerning and adds to existing
information gaps.
The Commission needs to update the treatment of certain
debt transactions when determining deal size for the purpose of
premerger notification. The current approach allows dealmakers to
structure anticompetitive transactions in ways that can go
unreported.
In September 1976, Congress gave the Federal Trade Commission an
important tool enabling it to block harmful mergers. The Hart-Scott-
Rodino Antitrust Improvements Act of 1976 (``HSR Act'') requires
prior notification to the antitrust agencies in advance of closing
certain mergers and acquisitions.\1\
---------------------------------------------------------------------------
\1\ Clayton Act section 7A, 15 U.S.C. 18a.
---------------------------------------------------------------------------
Prior to the HSR Act's enactment, companies could quickly
``scramble the eggs'' of assets and operations, or even shut down
functions. This made it extremely difficult for the antitrust
agencies to remedy competitive harms through divestitures of assets.
Years of protracted litigation to stop further damage and
distortions were often the result.\2\
---------------------------------------------------------------------------
\2\ For example, in United States v. El Paso Natural Gas Co.,
376 U.S. 651 (1964), it took seventeen years of litigation before a
divestiture finally took place.
---------------------------------------------------------------------------
The HSR Act fundamentally changed the process of merger review
by giving the antitrust agencies time to halt anticompetitive
transactions before these deals closed. Today, the FTC focuses a
substantial portion of its competition mission on investigating and
challenging mergers reported under the HSR Act. Importantly, only a
small set of transactions--the ones with the highest valuations--are
subject to premerger notification. The HSR Act specifies the
valuation threshold, currently set at $94 million, which is
typically adjusted upward each year. Since there are many ways to
determine a deal's valuation, Congress gave the FTC broad authority
to implement rules so that buyers know if they need to report their
transactions and what they are required to submit with their filing.
The Commission can also exempt classes of transactions and tailor
filing requirements.
While premerger notification filings provide the Commission with
certain nonpublic information,\3\ gathering and analyzing market
intelligence on transaction activity and competitive dynamics is a
major challenge. We need to continuously assess how we can enhance
our market monitoring techniques and evolve our analytical
approaches.
---------------------------------------------------------------------------
\3\ I agree with Commissioner Slaughter that current filing
requirements, including for minority stakes, can have the beneficial
effect of deterring certain anticompetitive transactions.
---------------------------------------------------------------------------
Today, the Commission is soliciting comment on two rulemakings
regarding our policies to implement the HSR Act's premerger
notification protocols. The first publication, a Notice of Proposed
Rulemaking, proposes specific rules and exemptions. While some of
the proposals are helpful improvements, I respectfully disagree with
our approach to exempting a broad swath of transactions from
reporting. The second publication, an Advance Notice of Proposed
Rulemaking, requests comment on a broad range of topics to set the
stage for modernizing the premerger notification program to align
with market realities. I support soliciting input to rethink our
approach. I discuss each of these rulemakings below.
Notice of Proposed Rulemaking
The Notice of Proposed Rulemaking outlines specific amendments
that the Commission is proposing to the HSR rules. The aggregation
and exemption provisions are particularly noteworthy. The
aggregation provisions are worthwhile, since they close a loophole
and align with market realities. However, I am concerned about the
exemption provisions, since we will completely lose visibility into
a large set of transactions involving non-controlling stakes.
Aggregation Provisions
The financial services industry is well known for using an
alphabet soup of small entities, like shell companies, partnerships,
and other investment vehicles, to structure deals. Even though they
may be under common management by the same person or group, like a
private equity fund or a hedge fund, these smaller legal entities
are all treated separately under the existing rules.
The proposed aggregation provisions will help to prevent
acquirers from splitting up
[[Page 77053]]
transactions into small slices across multiple investment vehicles
under their control to avoid reporting. The proposal would require
investors and other buyers to add together their stakes across
commonly managed funds to determine whether they need to report a
transaction.
Exemption Provisions
By creating a reporting threshold based on the value of a
transaction, the law already exempts most transactions from agency
review. Because of this, it is difficult to systematically track
these transactions, and even harder to detect and deter those that
are anticompetitive.
Now, the FTC is proposing to widen that information gap by
creating a new exemption for minority stakes of 10% or less, subject
to certain conditions. Importantly, the proposal is not exempting
specific aspects of the reporting requirements--it is a total
exemption, so the agency will receive no information whatsoever from
the buyer or the seller that the transaction even occurred. This
adds to the burdens and information asymmetries that the agency
already faces when it comes to detecting potentially harmful
transactions.\4\
---------------------------------------------------------------------------
\4\ The FTC may not be able to rely on other sources of robust
data required by other agencies. For example, the Securities and
Exchange Commission has proposed eliminating reporting for thousands
of registered investment funds that previously detailed their
holdings to the public. See Statement of SEC Comm'r Allison Herren
Lee Regarding Proposal to Substantially Reduce 13F Reporting (July
10, 2020), https://www.sec.gov/news/public-statement/lee-13f-reporting-2020-07-10.
---------------------------------------------------------------------------
Companies and investors purchase minority, non-controlling
stakes in a firm for a number of reasons. Sometimes, buyers might
start with a minority stake, with the goal--or even with a
contractual option--of an outright takeover as they learn more about
the company's operations. Even though they might have a small stake,
they can exert outsized control. In other cases, buyers might look
for minority stakes in multiple, competing firms within a sector or
industry, and some or all of these acquisitions may fall below the
reporting thresholds. Of course, if they are able to obtain seats on
boards of directors of competing companies, this can be illegal.
Investors and buyers can only use the proposed exemption if they
do not currently own stakes in firms that compete or do business
with the company they plan to acquire. Since many investors might
not know about the specific business dealings across companies, this
may be difficult to enforce and puts more burden on the agency.
Even if one believes that transactions involving a minority
stake are less likely to be illegal, there are many potential
alternatives to outright elimination of reporting. Unfortunately,
the rulemaking does not outline alternative approaches (such as
tailored, simplified filing requirements or shortened waiting
periods) for minority stakes.
Advance Notice of Proposed Rulemaking
As markets evolve, it is important that the HSR Act and its
implementing rules reflect those developments. The Advance Notice of
Proposed Rulemaking seeks input on a wide array of market-based
issues that may affect the Commission's merger oversight. One topic
of particular interest is whether to include debt as part of the
valuation of a transaction. Since the HSR Act's passage, corporate
debt markets have grown in importance for companies competing in
developed economies. Many major deals involve vast sums of borrowed
money.
However, the Commission has not formally codified a view on the
treatment of certain debt transactions. Instead, existing staff
guidance excludes many debt transactions from the deal's overall
value. This is worrisome, since it means that many potentially
anticompetitive transactions can go unreported, since they may fall
below the size threshold. In addition, this view has been provided
informally, communicated through unofficial interpretations outside
of formal rules or guidance. It will be important to take steps to
collect input and codify the Commission's policies on valuation,
particularly with respect to the treatment of debt, since formal
guidance or rules will offer clarity and will be easier to enforce.
The Advance Notice of Proposed Rulemaking also seeks information
that will lay groundwork for broader reforms to our premerger
notification program. I look forward to the data and written
submissions to this document.
Conclusion
Adequate premerger reporting is a helpful tool used to halt
anticompetitive transactions before too much damage is done.
However, the usefulness of the HSR Act only goes so far. This is
because many deals can quietly close without any notification and
reporting, since only transactions above a certain size are
reportable.\5\ The FTC ends up missing a large number of
anticompetitive mergers every year. In addition, since amendments to
the HSR Act in 2000 raised the size thresholds on an annual basis,
the number of HSR-reportable transactions has decreased.
---------------------------------------------------------------------------
\5\ Small transactions can be just as harmful to competition as
large transactions notified under the HSR Act. For example, ``catch
and kill'' acquisitions of an upstart competitor in fast-moving
markets can be particularly destructive. In addition, ``roll-ups,''
an acquisition strategy involving a series of acquisitions of small
players to combine into a larger one, can have very significant
negative effects on competition. See Statement of Fed. Trade Comm'r
Rohit Chopra Regarding Private Equity Roll-ups and the Hart-Scott
Rodino Annual Report to Congress, Comm'n File No. P110014 (July 8,
2020), https://www.ftc.gov/system/files/documents/public_statements/1577783/p110014hsrannualreportchoprastatement.pdf.
---------------------------------------------------------------------------
I want to commend agency staff for their work in identifying
potential blind spots in the premerger reporting regime. I also want
to thank state legislatures and state attorneys general for enacting
and implementing their own premerger notification laws to fill in
some of these gaps. For example, a new law in State of Washington
has taken effect, which requires advance notice of any transactions
in the health care sector, where many problematic mergers fall below
the radar.\6\
---------------------------------------------------------------------------
\6\ See Healthcare Transaction Notification Requirement, WASH.
STATE OFF. OF THE ATT'Y GEN. (last visited Sept. 16, 2020), https://www.atg.wa.gov/healthcare-transactions-notification-requirement; see
also S.H.B. 1607, 66th Leg., Reg. Sess. (Wash. 2019).
---------------------------------------------------------------------------
As we conduct this examination of the HSR Act, we should
identify areas where laws may need to be changed or updated,
especially when we cannot fill those gaps through amendments to our
rules. For example, we may need to pursue reforms to ensure that
``roll ups'' are reported, where a buyer might acquire a large
number of small companies that may not be individually reportable.
We may also need to look carefully at the length of the waiting
period, to determine if it is long enough to conduct a thorough
investigation. I look forward to reviewing the input to these two
rulemakings, so that our approach reflects market realities.
[FR Doc. 2020-21754 Filed 11-30-20; 8:45 am]
BILLING CODE 6750-01-P